| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 MYO9A MYO9B CFTR MYO5C CLPB RALBP1 ABCC8 DDX60L RAD17 EP400 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 ATP1A3 | 5.90e-07 | 614 | 227 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO9B CFTR CLPB ABCC8 DDX60L RAD17 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 ATP1A3 | 3.22e-06 | 441 | 227 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D9B TRIO MYO9A MYO9B TBC1D9 SH3BP4 FARP2 RALBP1 SGSM2 SGSM3 MCF2L RASAL2 IQSEC3 IPO7 RASGRF1 RASA3 ARFGEF3 RABEP1 AKAP13 | 5.86e-06 | 507 | 227 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D9B TRIO MYO9A MYO9B TBC1D9 SH3BP4 FARP2 RALBP1 SGSM2 SGSM3 MCF2L RASAL2 IQSEC3 IPO7 RASGRF1 RASA3 ARFGEF3 RABEP1 AKAP13 | 5.86e-06 | 507 | 227 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.39e-05 | 18 | 227 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.89e-05 | 37 | 227 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.17e-05 | 118 | 227 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin binding | MYH9 TRPM7 MYO9A MYO9B PARVB MYO5C SPTBN5 DST SVIL SYNE2 DMD UTRN NOS2 SLC6A2 MACF1 CTNNA1 | 1.26e-04 | 479 | 227 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | MYH9 ILK FASN DST NRXN1 DMD UTRN NOS2 CCS GRIN2A PAICS PPL CCT8 MACF1 CTNNA1 CTNND1 CDH4 SNX1 | 1.80e-04 | 599 | 227 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.03e-04 | 140 | 227 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.69e-04 | 28 | 227 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | small GTPase binding | KNTC1 MYO9B SH3BP4 RALBP1 SGSM2 SGSM3 IPO7 RASGRF1 DVL1 XPO4 IPO13 AKAP13 | 3.25e-04 | 321 | 227 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D9B TRIO MYO9A MYO9B BIRC6 NEK9 TBC1D9 SH3BP4 FARP2 SPINK4 PSME4 RALBP1 SGSM2 SGSM3 MCF2L NOS2 RASAL2 IQSEC3 IPO7 RASGRF1 RASA3 CCNF ARFGEF3 PPP2R1A PPP2R1B RABEP1 PYCARD SERPINE1 CCAR2 AKAP13 AKAP11 | 3.45e-04 | 1418 | 227 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.76e-04 | 193 | 227 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | vinculin binding | 3.81e-04 | 13 | 227 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.02e-04 | 31 | 227 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.37e-04 | 197 | 227 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.14e-04 | 33 | 227 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | cadherin binding | MYH9 FASN NOS2 CCS PAICS PPL CCT8 MACF1 CTNNA1 CTNND1 CDH4 SNX1 | 5.30e-04 | 339 | 227 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM7 TRPM2 TRPM5 NALCN ABCC8 PKD1 KCNN1 ATP5PD RASA3 HCN3 GRIN2A ANO6 | 5.87e-04 | 343 | 227 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | transporter activity | TRPM7 CFTR TRPM2 PITPNC1 SLC22A17 SLC35D1 TRPM5 CLCN1 NALCN RALBP1 ABCC8 PKD1 KCNN1 ATP5PD RASA3 GRAMD1A HCN3 GRIN2A SLC44A4 ABCC6 SLC3A1 SLC6A2 OSBP SLC12A1 ANO6 SLC28A1 ATP1A3 M6PR | 7.52e-04 | 1289 | 227 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.75e-04 | 171 | 227 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM7 CFTR TRPM2 TRPM5 CLCN1 NALCN ABCC8 PKD1 KCNN1 ATP5PD RASA3 HCN3 GRIN2A ANO6 | 8.14e-04 | 459 | 227 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | microfilament motor activity | 8.87e-04 | 38 | 227 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | GTPase binding | KNTC1 MYO9B SH3BP4 RALBP1 SGSM2 SGSM3 IPO7 RASGRF1 DVL1 XPO4 IPO13 AKAP13 | 8.95e-04 | 360 | 227 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM7 TRPM2 TRPM5 NALCN ABCC8 PKD1 KCNN1 RASA3 HCN3 GRIN2A SLC6A2 SLC12A1 SLC28A1 ATP1A3 | 9.22e-04 | 465 | 227 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 9.86e-04 | 137 | 227 | 7 | GO:0019783 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM7 CFTR TRPM2 TRPM5 CLCN1 NALCN ABCC8 PKD1 KCNN1 ATP5PD RASA3 HCN3 GRIN2A ABCC6 SLC6A2 SLC12A1 ANO6 SLC28A1 ATP1A3 | 1.10e-03 | 758 | 227 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D9B MYO9A MYO9B TBC1D9 RALBP1 SGSM2 SGSM3 RASAL2 RASA3 RABEP1 | 1.39e-03 | 279 | 227 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYO9B CFTR CLPB ABCC8 DDX60L RAD17 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 RAB15 ATP1A3 | 1.43e-03 | 775 | 227 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | proteasome binding | 1.43e-03 | 20 | 227 | 3 | GO:0070628 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYO9B CFTR TRPM2 CLPB ABCC8 DDX60L RAD17 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 RAB15 ATP1A3 | 1.50e-03 | 839 | 227 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYO9B CFTR TRPM2 CLPB ABCC8 DDX60L RAD17 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 RAB15 ATP1A3 | 1.52e-03 | 840 | 227 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYO9B CFTR TRPM2 CLPB ABCC8 DDX60L RAD17 DYNC2H1 DNAH2 RECQL DNAH7 ABCC6 DNAH12 EIF4A1 MCM9 HELZ2 CCT8 MACF1 RAB15 ATP1A3 | 1.52e-03 | 840 | 227 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.94e-03 | 114 | 227 | 6 | GO:0004843 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.31e-03 | 49 | 227 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.52e-03 | 120 | 227 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | acyl-CoA oxidase activity | 2.60e-03 | 7 | 227 | 2 | GO:0003997 | |
| GeneOntologyBiologicalProcess | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | 1.71e-05 | 15 | 225 | 4 | GO:2001241 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | CFTR TRPM2 TRPM5 NALCN DMD UTRN HCN3 SLC6A2 SLC12A1 ANO6 ATP1A3 | 1.88e-05 | 208 | 225 | 11 | GO:0035725 |
| GeneOntologyCellularComponent | costamere | 8.64e-05 | 22 | 228 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 ILK TRPM7 MYO9B PARVB DST PTPRK SYNE2 DMD MCF2L CDC42BPG GRIN2A MACF1 CTNNA1 CTNND1 SNX1 | 1.29e-04 | 500 | 228 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | inner dynein arm | 1.45e-04 | 10 | 228 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.46e-04 | 25 | 228 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | lamellipodium | 2.27e-04 | 230 | 228 | 10 | GO:0030027 | |
| GeneOntologyCellularComponent | sarcolemma | 2.49e-04 | 190 | 228 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | dynein complex | 3.02e-04 | 54 | 228 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | peroxisome | 4.15e-04 | 162 | 228 | 8 | GO:0005777 | |
| GeneOntologyCellularComponent | microbody | 4.15e-04 | 162 | 228 | 8 | GO:0042579 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.58e-04 | 90 | 228 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | myosin complex | 4.58e-04 | 59 | 228 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | axoneme | CFAP251 ODAD1 SPTBN5 DYNC2H1 DNAH2 DNAH7 KIFAP3 DNAH12 CFAP46 | 4.66e-04 | 207 | 228 | 9 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | CFAP251 ODAD1 SPTBN5 DYNC2H1 DNAH2 DNAH7 KIFAP3 DNAH12 CFAP46 | 4.82e-04 | 208 | 228 | 9 | GO:0097014 |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 MYH9 ILK MYO9A MYO9B PARVB PGM5 MYO5C AFAP1L1 SPTBN5 DST SVIL MYH16 MACF1 AKAP13 CTNNA1 | 6.17e-04 | 576 | 228 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | cytoplasmic region | CFAP251 ODAD1 SPTBN5 DST AKR1B1 DYNC2H1 DNAH2 DNAH7 KIFAP3 DNAH12 CTNND1 CFAP46 | 6.27e-04 | 360 | 228 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CFAP251 ODAD1 SPTBN5 DST AKR1B1 DYNC2H1 DNAH2 DNAH7 KIFAP3 DNAH12 CFAP46 | 7.57e-04 | 317 | 228 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CFTR TRPM5 CLCN1 NALCN ABCC8 PKD1 KCNN1 ATP5PD AKAP6 HCN3 GRIN2A ANO6 | 9.58e-04 | 378 | 228 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 9.87e-04 | 230 | 228 | 9 | GO:0019898 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 1.27e-03 | 20 | 228 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.47e-03 | 21 | 228 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | Cul4B-RING E3 ubiquitin ligase complex | 1.73e-03 | 6 | 228 | 2 | GO:0031465 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.98e-03 | 161 | 228 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KNTC1 MYH9 MYO9A MYO9B DST SVIL DMD BFSP2 DYNC2H1 DVL1 DNAH2 DNAH7 PPL KIFAP3 DNAH12 TTLL6 PYCARD CCT8 MACF1 AKAP13 | 2.08e-03 | 899 | 228 | 20 | GO:0099513 |
| Domain | SPEC | 2.70e-12 | 32 | 225 | 10 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.70e-12 | 32 | 225 | 10 | IPR018159 | |
| Domain | Spectrin_repeat | 3.70e-11 | 29 | 225 | 9 | IPR002017 | |
| Domain | Spectrin | 1.64e-10 | 23 | 225 | 8 | PF00435 | |
| Domain | ARM-type_fold | USP34 USP9Y TRRAP LYST EFR3A PSME4 PIK3CG ANKAR NCAPD2 IPO7 HEATR4 XPO4 ARFGEF3 KIFAP3 PPP2R1A PPP2R1B MROH1 IPO13 ATM CTNND1 | 5.63e-09 | 339 | 225 | 20 | IPR016024 |
| Domain | ACTININ_2 | 2.43e-07 | 23 | 225 | 6 | PS00020 | |
| Domain | ACTININ_1 | 2.43e-07 | 23 | 225 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.43e-07 | 23 | 225 | 6 | IPR001589 | |
| Domain | - | TRRAP EFR3A PSME4 ANKAR NCAPD2 IPO7 HEATR4 XPO4 KIFAP3 PPP2R1A PPP2R1B MROH1 IPO13 CTNND1 | 5.29e-07 | 222 | 225 | 14 | 1.25.10.10 |
| Domain | ARM-like | USP9Y TRRAP EFR3A PSME4 ANKAR NCAPD2 IPO7 HEATR4 XPO4 KIFAP3 PPP2R1A PPP2R1B MROH1 IPO13 CTNND1 | 1.04e-06 | 270 | 225 | 15 | IPR011989 |
| Domain | AAA+_ATPase | CFTR CLPB ABCC8 RAD17 DYNC2H1 DNAH2 DNAH7 ABCC6 DNAH12 MCM9 HELZ2 | 1.40e-06 | 144 | 225 | 11 | IPR003593 |
| Domain | AAA | CFTR CLPB ABCC8 RAD17 DYNC2H1 DNAH2 DNAH7 ABCC6 DNAH12 MCM9 HELZ2 | 1.40e-06 | 144 | 225 | 11 | SM00382 |
| Domain | PH | TRIO PLEKHM1 AFAP1L1 FARP2 SPTBN5 MCF2L RASAL2 CDC42BPG IQSEC3 RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 7.43e-06 | 278 | 225 | 14 | SM00233 |
| Domain | PH_DOMAIN | TRIO PLEKHM1 AFAP1L1 FARP2 SPTBN5 MCF2L RASAL2 CDC42BPG IQSEC3 RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 7.74e-06 | 279 | 225 | 14 | PS50003 |
| Domain | PH_domain | TRIO PLEKHM1 AFAP1L1 FARP2 SPTBN5 MCF2L RASAL2 CDC42BPG IQSEC3 RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 8.06e-06 | 280 | 225 | 14 | IPR001849 |
| Domain | CH | 1.29e-05 | 65 | 225 | 7 | SM00033 | |
| Domain | AAA_8 | 1.87e-05 | 14 | 225 | 4 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.87e-05 | 14 | 225 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.87e-05 | 14 | 225 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.87e-05 | 14 | 225 | 4 | PF08393 | |
| Domain | CH | 2.11e-05 | 70 | 225 | 7 | PF00307 | |
| Domain | USP_1 | 2.11e-05 | 70 | 225 | 7 | PS00972 | |
| Domain | USP_2 | 2.32e-05 | 71 | 225 | 7 | PS00973 | |
| Domain | - | 2.32e-05 | 71 | 225 | 7 | 1.10.418.10 | |
| Domain | DHC_fam | 2.52e-05 | 15 | 225 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.52e-05 | 15 | 225 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.52e-05 | 15 | 225 | 4 | IPR004273 | |
| Domain | USP_dom | 2.54e-05 | 72 | 225 | 7 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.54e-05 | 72 | 225 | 7 | IPR001394 | |
| Domain | USP_3 | 2.54e-05 | 72 | 225 | 7 | PS50235 | |
| Domain | CH | 2.78e-05 | 73 | 225 | 7 | PS50021 | |
| Domain | CH-domain | 3.32e-05 | 75 | 225 | 7 | IPR001715 | |
| Domain | Plectin | 5.83e-05 | 7 | 225 | 3 | PF00681 | |
| Domain | Plectin_repeat | 5.83e-05 | 7 | 225 | 3 | IPR001101 | |
| Domain | PLEC | 5.83e-05 | 7 | 225 | 3 | SM00250 | |
| Domain | HEAT | 6.86e-05 | 58 | 225 | 6 | IPR000357 | |
| Domain | PH | TRIO AFAP1L1 FARP2 SPTBN5 MCF2L CDC42BPG RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 1.09e-04 | 229 | 225 | 11 | PF00169 |
| Domain | ZF_DAG_PE_2 | 1.20e-04 | 64 | 225 | 6 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 1.20e-04 | 64 | 225 | 6 | PS00479 | |
| Domain | C1 | 1.31e-04 | 65 | 225 | 6 | SM00109 | |
| Domain | USP_CS | 1.42e-04 | 66 | 225 | 6 | IPR018200 | |
| Domain | PE/DAG-bd | 1.42e-04 | 66 | 225 | 6 | IPR002219 | |
| Domain | DVL-1 | 1.44e-04 | 2 | 225 | 2 | IPR008340 | |
| Domain | PP2A_A_meta | 1.44e-04 | 2 | 225 | 2 | IPR031090 | |
| Domain | Dystrophin | 1.44e-04 | 2 | 225 | 2 | IPR016344 | |
| Domain | HEAT_REPEAT | 1.97e-04 | 70 | 225 | 6 | PS50077 | |
| Domain | IQ | 2.13e-04 | 71 | 225 | 6 | PF00612 | |
| Domain | UCH | 2.13e-04 | 71 | 225 | 6 | PF00443 | |
| Domain | PH_dom-like | TRIO LYST PLEKHM1 AFAP1L1 FARP2 SPTBN5 MCF2L RASAL2 CDC42BPG IQSEC3 RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 2.15e-04 | 426 | 225 | 15 | IPR011993 |
| Domain | HEAT | 2.73e-04 | 48 | 225 | 5 | PF02985 | |
| Domain | - | TRIO PLEKHM1 AFAP1L1 FARP2 SPTBN5 MCF2L RASAL2 CDC42BPG IQSEC3 RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 2.94e-04 | 391 | 225 | 14 | 2.30.29.30 |
| Domain | Pur_nucleotidase | 4.30e-04 | 3 | 225 | 2 | IPR016695 | |
| Domain | RabGAP-TBC | 4.35e-04 | 53 | 225 | 5 | PF00566 | |
| Domain | Rab-GTPase-TBC_dom | 5.17e-04 | 55 | 225 | 5 | IPR000195 | |
| Domain | TBC_RABGAP | 5.17e-04 | 55 | 225 | 5 | PS50086 | |
| Domain | ATPase_dyneun-rel_AAA | 5.69e-04 | 14 | 225 | 3 | IPR011704 | |
| Domain | MT | 5.69e-04 | 14 | 225 | 3 | PF12777 | |
| Domain | AAA_5 | 5.69e-04 | 14 | 225 | 3 | PF07728 | |
| Domain | Dynein_HC_stalk | 5.69e-04 | 14 | 225 | 3 | IPR024743 | |
| Domain | - | CFAP251 BIRC6 LYST DDB2 HIRA WDR77 WDR72 THOC6 TBC1D31 KCTD3 NUP133 HPS5 | 7.48e-04 | 333 | 225 | 12 | 2.130.10.10 |
| Domain | IQ_motif_EF-hand-BS | 7.67e-04 | 90 | 225 | 6 | IPR000048 | |
| Domain | WD40/YVTN_repeat-like_dom | CFAP251 BIRC6 LYST DDB2 HIRA WDR77 WDR72 THOC6 TBC1D31 KCTD3 NUP133 HPS5 | 7.88e-04 | 335 | 225 | 12 | IPR015943 |
| Domain | Dishevelled | 8.53e-04 | 4 | 225 | 2 | PF02377 | |
| Domain | Acyl-CoA_oxidase_C | 8.53e-04 | 4 | 225 | 2 | IPR002655 | |
| Domain | HAD-SF_hydro_IG_5-nucl | 8.53e-04 | 4 | 225 | 2 | IPR008380 | |
| Domain | Dishevelled_fam | 8.53e-04 | 4 | 225 | 2 | IPR008339 | |
| Domain | ACOX | 8.53e-04 | 4 | 225 | 2 | PF01756 | |
| Domain | 5_nucleotid | 8.53e-04 | 4 | 225 | 2 | PF05761 | |
| Domain | Dishevelled_protein_dom | 8.53e-04 | 4 | 225 | 2 | IPR003351 | |
| Domain | Acyl-CoA_oxidase | 8.53e-04 | 4 | 225 | 2 | IPR012258 | |
| Domain | WD40_repeat_CS | 8.56e-04 | 164 | 225 | 8 | IPR019775 | |
| Domain | GRAM | 8.60e-04 | 16 | 225 | 3 | SM00568 | |
| Domain | PI3Kc | 8.60e-04 | 16 | 225 | 3 | SM00146 | |
| Domain | - | 8.60e-04 | 16 | 225 | 3 | 1.10.1070.11 | |
| Domain | IQ | 9.11e-04 | 93 | 225 | 6 | PS50096 | |
| Domain | DH_1 | 9.67e-04 | 63 | 225 | 5 | PS00741 | |
| Domain | WD40_repeat_dom | KNTC1 CFAP251 LYST DDB2 HIRA WDR77 WDR72 THOC6 TBC1D31 KCTD3 HPS5 | 9.90e-04 | 297 | 225 | 11 | IPR017986 |
| Domain | HEAT_type_2 | 1.04e-03 | 17 | 225 | 3 | IPR021133 | |
| Domain | MYOSIN_MOTOR | 1.10e-03 | 38 | 225 | 4 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.10e-03 | 38 | 225 | 4 | IPR001609 | |
| Domain | Myosin_head | 1.10e-03 | 38 | 225 | 4 | PF00063 | |
| Domain | MYSc | 1.10e-03 | 38 | 225 | 4 | SM00242 | |
| Domain | GDS_CDC24_CS | 1.21e-03 | 39 | 225 | 4 | IPR001331 | |
| Domain | RUN | 1.23e-03 | 18 | 225 | 3 | SM00593 | |
| Domain | PI3/4_kinase_cat_dom | 1.23e-03 | 18 | 225 | 3 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.23e-03 | 18 | 225 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.23e-03 | 18 | 225 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.23e-03 | 18 | 225 | 3 | PS00916 | |
| Domain | PI3_4_KINASE_3 | 1.23e-03 | 18 | 225 | 3 | PS50290 | |
| Domain | RhoGEF | 1.37e-03 | 68 | 225 | 5 | SM00325 | |
| Domain | zf-RING_9 | 1.41e-03 | 5 | 225 | 2 | PF13901 | |
| Domain | Zf-RING_9 | 1.41e-03 | 5 | 225 | 2 | IPR025258 | |
| Domain | DUF4206 | 1.41e-03 | 5 | 225 | 2 | SM01175 | |
| Domain | Run_dom | 1.45e-03 | 19 | 225 | 3 | IPR004012 | |
| Domain | RUN | 1.45e-03 | 19 | 225 | 3 | PS50826 | |
| Domain | RUN | 1.45e-03 | 19 | 225 | 3 | PF02759 | |
| Domain | RhoGEF | 1.56e-03 | 70 | 225 | 5 | PF00621 | |
| Domain | DH_2 | 1.56e-03 | 70 | 225 | 5 | PS50010 | |
| Domain | - | 1.66e-03 | 71 | 225 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.66e-03 | 71 | 225 | 5 | IPR000219 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 TBC1D9B KMT2B MAN2B1 TRIO MYO9B PARVB TTC3 TRRAP BIRC6 LYST PLEKHM1 ACOX3 TBC1D9 HIRA SH3BP4 FASN DST PSME4 SGSM2 PKD1 NCAPD2 MCF2L EP400 RASA3 DUSP5 DVL1 MYOF MROH1 DNAJC14 HELZ2 PDCD11 AKAP13 POFUT1 | 1.23e-13 | 1105 | 232 | 34 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 ILK MYO9A MYO9B DARS1 RRBP1 TRRAP BIRC6 NEK9 NKRF HIRA FASN DST PELO PSME4 UBR5 NCAPD2 DDX60L UTRN RASAL2 AIMP2 IPO7 EP400 RASA3 RECQL FASTKD2 XPC PAICS PPP2R1A EIF4A1 NUP133 CCT8 PDCD11 MACF1 CCAR2 AKAP13 CTNND1 | 3.21e-13 | 1353 | 232 | 37 | 29467282 |
| Pubmed | USP34 TRIO TRPM7 TSPYL2 DARS1 PARVB RRBP1 USP9Y TTC3 CCDC13 DGLUCY DST CLPB PTPRK SACS RALBP1 SGSM2 PKD1 KCNN1 SGSM3 UTRN RASAL2 AKAP6 USP13 XPC JAKMIP3 PAICS DNAJC14 RABEP1 EIF4A1 MACF1 CTNNA1 ATM USPL1 SNX1 | 1.70e-12 | 1285 | 232 | 35 | 35914814 | |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | MYO9A MYO9B TRRAP NEK9 MYO5C PELO PSME4 WDR77 IPO7 EP400 EIF4A1 NUP133 IPO13 CCT8 CCAR2 | 1.55e-11 | 211 | 232 | 15 | 17314511 |
| Pubmed | USP34 RRBP1 BIRC6 RTF1 DST NRXN1 UBR5 SYNE2 AKAP6 MYOF HELZ2 MACF1 AKAP11 POFUT1 HPS5 | 3.86e-11 | 225 | 232 | 15 | 12168954 | |
| Pubmed | KNTC1 USP34 TBC1D9B PTGFRN NKRF HIRA FASN DST PELO CLPB UBR5 SYNE2 NCAPD2 DDX60L ATP5PD WDR77 TMED1 IPO7 GRAMD1A XPO4 RECQL PAICS ARFGEF3 MYOF PPP2R1A PPP2R1B EIF4A1 SERPINE1 NUP133 IPO13 CCT8 PDCD11 CCAR2 CTNNA1 ATM | 3.97e-11 | 1440 | 232 | 35 | 30833792 | |
| Pubmed | USP34 MYH9 TRRAP BIRC6 NKRF FASN DST UBR5 SYNE2 NCAPD2 UTRN IPO7 RECQL PAICS PPP2R1A EIF4A1 HELZ2 NUP133 PDCD11 MACF1 CCAR2 CTNNA1 ATM | 1.10e-10 | 653 | 232 | 23 | 22586326 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 MYH9 MAN2B1 PTDSS2 RRBP1 PTGFRN NEK9 USP19 PTPRK MANEAL SVIL SCAPER ATP5PD TMED1 FOLR1 GRAMD1A RECQL PAICS MYOF FSTL1 ANO6 SERPINE1 SLITRK5 IPO13 CCT8 POFUT1 CTNNA1 ATM NGLY1 M6PR SNX1 | 1.36e-10 | 1201 | 232 | 31 | 35696571 |
| Pubmed | MYH9 LZTS3 TRIO TRIM21 LRRTM1 TTC3 NEK9 HIRA CCDC13 DST NRXN1 UBR5 SVIL SYNE2 RASAL2 IQSEC3 HCN3 GRIN2A JAKMIP3 PPP2R1A RABEP1 EIF4A1 CCT8 MACF1 CCAR2 CTNNA1 CTNND1 | 3.93e-10 | 963 | 232 | 27 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 OTOL1 FASN CLPB PTPRK UBR5 DMD UTRN ATP5PD WDR77 TMED1 IPO7 POLE2 GRAMD1A DUSP5 XPO4 PAICS PPL PPP2R1A PPP2R1B NT5DC2 KCTD3 NUP133 CCT8 CCAR2 CTNNA1 NGLY1 | 5.03e-10 | 974 | 232 | 27 | 28675297 |
| Pubmed | KNTC1 MYH9 RRBP1 TTC3 LYST FASN DST NRXN1 SACS FAM186A SYNE2 PGAM4 NCAPD2 PKHD1 DMD MCF2L ATP5PD PPFIA2 DNAH2 XPC PPL THOC6 ADAMTS12 TBC1D31 EIF4A1 MACF1 CCAR2 POFUT1 ATM NGLY1 ATP1A3 USPL1 CFAP46 | 7.04e-10 | 1442 | 232 | 33 | 35575683 | |
| Pubmed | KMT2B MAN2B1 RRBP1 TTC3 ACOX3 DST PAPOLA CLPB UBR5 PKD1 AKR1B1 UTRN TOM1L2 TMED1 USP13 XPC PPL PPP2R1A CEP250 MACF1 | 3.75e-09 | 591 | 232 | 20 | 15231748 | |
| Pubmed | TRPM7 RRBP1 TTC3 SH3BP4 EFR3A CLPB SACS UBR5 CASKIN2 SYNE2 ATP5PD RASAL2 IPO7 DYNC2H1 POLE2 GRAMD1A GPAT3 FASTKD2 TBC1D31 DNAJC14 ANO6 NT5DC2 NUP133 PDCD11 MACF1 AKAP13 AKAP11 CTNNA1 ATM CTNND1 M6PR SNX1 | 5.76e-09 | 1487 | 232 | 32 | 33957083 | |
| Pubmed | TRIO MYO9A RRBP1 DST UBR5 UTRN RASAL2 ARFGEF3 RABEP1 MACF1 AKAP11 CTNND1 | 1.93e-08 | 209 | 232 | 12 | 36779422 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ILK TRIO TRPM7 MYO9A PITPNC1 LYST NEK9 SH3BP4 DST CASKIN2 SVIL SYNE2 UTRN RASAL2 USP43 DNAH7 ARFGEF3 RABEP1 MACF1 AKAP13 AKAP11 PLEKHM3 CTNND1 | 2.07e-08 | 861 | 232 | 23 | 36931259 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 DARS1 TRIM21 RRBP1 NKRF AFAP1L1 FASN DST SVIL WDR77 RASAL2 AIMP2 IPO7 RECQL PAICS PPL THOC6 MYOF PPP2R1A EIF4A1 SERPINE1 HELZ2 NUP133 CCT8 PDCD11 RAB15 CTNNA1 CTNND1 | 2.75e-08 | 1257 | 232 | 28 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO9B DARS1 RRBP1 TRRAP NKRF MYO5C FASN DST SACS UBR5 SVIL SYNE2 UTRN ATP5PD IPO7 EP400 PPP2R1A EIF4A1 NUP133 CCT8 PDCD11 MACF1 CCAR2 CTNNA1 CTNND1 | 2.82e-08 | 1024 | 232 | 25 | 24711643 |
| Pubmed | MYH9 CFTR DARS1 TRIM21 RRBP1 FASN DMD PPL PPP2R1A PPP2R1B EIF4A1 SERPINE1 CCT8 MACF1 RAB15 CTNNA1 CTNND1 | 3.81e-08 | 488 | 232 | 17 | 31324722 | |
| Pubmed | USP34 MYO9A DST PSME4 SYNE2 DMD CCS DYNC2H1 FSTL1 MACF1 CTNNA1 CTNND1 ATP1A3 CDH4 | 4.23e-08 | 322 | 232 | 14 | 26514267 | |
| Pubmed | 4.43e-08 | 76 | 232 | 8 | 27542412 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 USP34 MYH9 ILK MAN2B1 DARS1 BIRC6 DDB2 NEK9 USP19 RTF1 FASN PSME4 PAPOLA NCAPD2 WDR77 AIMP2 IPO7 RECQL PAICS PPP2R1A PPP2R1B OSBP RABEP1 NUP133 CCT8 MACF1 CCAR2 CTNNA1 SNX1 | 4.65e-08 | 1455 | 232 | 30 | 22863883 |
| Pubmed | TRIM21 TRRAP SPTBN5 DST SYNE2 PKD1 DMD WDR77 DYNC2H1 EIF4A1 CCT8 | 5.96e-08 | 187 | 232 | 11 | 26460568 | |
| Pubmed | MYH9 MYO9A MYO9B ACOX1 DARS1 SLC22A17 FASN DST CLPB DMD UTRN IPO7 FASTKD2 PAICS PPP2R1A NT5DC2 EIF4A1 CCT8 MACF1 CTNNA1 CTNND1 SNX1 | 6.54e-08 | 844 | 232 | 22 | 25963833 | |
| Pubmed | USP34 MYH9 KDM5C RRBP1 TRRAP DDB2 NKRF RTF1 FASN PAPOLA UBR5 NCAPD2 AKR1B1 USP13 IPO7 EP400 RECQL PPP2R1A EIF4A1 NUP133 CCT8 CCAR2 ATM CTNND1 | 9.63e-08 | 1014 | 232 | 24 | 32416067 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B PTDSS2 PTGFRN USP19 FASN PELO PTPRK UBR5 NCAPD2 ANAPC5 TOM1L2 IPO7 DYNC2H1 GRAMD1A DNAH2 ARFGEF3 PPP2R1A RABEP1 EIF4A1 NUP133 POFUT1 CTNNA1 ATP1A3 | 1.04e-07 | 942 | 232 | 23 | 31073040 |
| Pubmed | MYH9 LZTS3 TRIO MYO9A DARS1 LRRTM1 RRBP1 FASN DST SACS SVIL PGAM4 SCAPER DMD AKR1B1 UTRN ATP5PD RASAL2 TOM1L2 IQSEC3 PPFIA2 GRIN2A NT5DC3 PPP2R1A CCT8 MACF1 CTNNA1 CTNND1 ATP1A3 | 1.14e-07 | 1431 | 232 | 29 | 37142655 | |
| Pubmed | USP34 KDM5C RRBP1 EFR3A DST PSME4 USP38 CASKIN2 NCAPD2 AKAP6 EP400 XPO4 FASTKD2 IPO13 PDCD11 AKAP11 HPS5 | 1.21e-07 | 529 | 232 | 17 | 14621295 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | KNTC1 MYH9 TRIO MYO9B RRBP1 MYO5C FASN NCAPD2 IPO7 MYOF AKAP13 | 1.30e-07 | 202 | 232 | 11 | 33005030 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 ILK TRIO RRBP1 TRRAP LYST NEK9 ACOX3 RTF1 DST CLPB RALBP1 SCAPER DDX60L ANAPC5 UTRN PAICS MYOF PPP2R1A NUP133 AKAP11 CTNND1 | 2.37e-07 | 910 | 232 | 22 | 36736316 |
| Pubmed | KNTC1 TBC1D9B BIRC6 PTGFRN NEK9 TBC1D9 FARP2 SACS SCAPER DYNC2H1 GRAMD1A MYOF HELZ2 SLITRK5 CCT8 MACF1 | 2.51e-07 | 493 | 232 | 16 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRIO MYO9A TRPM2 TSPYL2 PARVB RRBP1 TTC3 TRRAP NEK9 PLEKHM1 SH3BP4 FARP2 ABCC8 SGSM2 ANKAR MCF2L UTRN CDC42BPG AIMP2 RASA3 PPFIA2 ARFGEF3 PPP2R1B RABEP1 MACF1 AKAP13 CTNND1 HPS5 ERMARD | 2.61e-07 | 1489 | 232 | 29 | 28611215 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KDM5C RRBP1 USP9Y TRRAP IGHV3-64D RTF1 NCAPD2 PHOX2B RECQL PAICS PPP2R1A DNAH12 CTNNA1 ATM CTNND1 NACA4P | 2.80e-07 | 497 | 232 | 16 | 36774506 |
| Pubmed | ILK TRIO GON4L TTC3 BIRC6 NEK9 DST RALBP1 SYNE2 UTRN AKAP6 IPO7 FSTL1 RABEP1 NUP133 MACF1 | 2.80e-07 | 497 | 232 | 16 | 23414517 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | TRPM7 SH3BP4 EFR3A DST PTPRK CASKIN2 DMD UTRN RASAL2 RASA3 MYOF ANO6 CTNNA1 CTNND1 | 2.90e-07 | 377 | 232 | 14 | 38117590 |
| Pubmed | 2.93e-07 | 3 | 232 | 3 | 7890770 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | DARS1 FASN UBR5 WDR77 PAICS PPP2R1A PPP2R1B EIF4A1 CCT8 ATP1A3 | 3.14e-07 | 175 | 232 | 10 | 25756610 |
| Pubmed | ILK TRIO DARS1 RRBP1 NKRF DST UBR5 SVIL TOM1L2 GPAT3 FASTKD2 XPC THOC6 MCM9 PDCD11 MACF1 CTNNA1 CTNND1 | 3.16e-07 | 634 | 232 | 18 | 34591612 | |
| Pubmed | TRPM7 RRBP1 LYST PLEKHM1 SH3BP4 DST SYNE2 RASAL2 GRAMD1A GPAT3 ARFGEF3 ANO6 AKAP11 PLEKHM3 CTNND1 SNX1 | 3.37e-07 | 504 | 232 | 16 | 34432599 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 MYH9 TRIO DARS1 RRBP1 TTC3 NEK9 USP19 FASN CLPB NCAPD2 AKR1B1 WDR77 RASAL2 IPO7 DYNC2H1 RECQL FASTKD2 PAICS PPP2R1A NT5DC2 EIF4A1 NUP133 CCT8 PDCD11 CCAR2 ATM CTNND1 | 3.59e-07 | 1425 | 232 | 28 | 30948266 |
| Pubmed | MYH9 NEK9 FASN NCAPD2 UTRN TOM1L2 IPO7 PAICS PPP2R1A RABEP1 EIF4A1 CCT8 RAB15 CTNND1 SNX1 | 4.18e-07 | 449 | 232 | 15 | 31732153 | |
| Pubmed | MYH9 TRIO MYO9B KDM5C TTC3 FASN DST SACS SVIL MYOF HELZ2 MACF1 CTNNA1 | 4.28e-07 | 332 | 232 | 13 | 37433992 | |
| Pubmed | 6.94e-07 | 147 | 232 | 9 | 29576527 | ||
| Pubmed | 7.03e-07 | 191 | 232 | 10 | 33762435 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 15936019 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 8954775 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 23422745 | ||
| Pubmed | A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. | 1.17e-06 | 4 | 232 | 3 | 11536079 | |
| Pubmed | MYH9 ILK MYO9B ACOX1 DARS1 BIRC6 ACOX3 FASN UBR5 PIK3CG NCAPD2 PEX16 AIMP2 IPO7 RECQL PAICS DNAJC14 ANO6 EIF4A1 HELZ2 NUP133 AKAP13 POFUT1 M6PR | 1.21e-06 | 1168 | 232 | 24 | 19946888 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B KDM5C RRBP1 TRRAP USP19 TBC1D9 FASN PAPOLA SVIL ANAPC5 EP400 XPC PPL MYOF OSBP HELZ2 CCAR2 CTNNA1 ATM | 1.30e-06 | 774 | 232 | 19 | 15302935 |
| Pubmed | TRIM21 SH3BP4 FARP2 SVIL WDR77 CCS RASAL2 RABEP1 CEP250 AKAP13 CTNND1 | 1.32e-06 | 255 | 232 | 11 | 15324660 | |
| Pubmed | USP34 MYH9 TRPM7 BIRC6 USP19 SH3BP4 DST UBR5 RASAL2 EP400 DNAH7 PPL ARFGEF3 ANO6 SLITRK5 CCT8 CCAR2 CTNND1 SNX1 | 1.38e-06 | 777 | 232 | 19 | 35844135 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 EFR3A FASN DST CASKIN2 SVIL UTRN CCS USP43 PAICS PPL CCT8 MACF1 CTNNA1 CTNND1 SNX1 | 1.51e-06 | 565 | 232 | 16 | 25468996 |
| Pubmed | 1.83e-06 | 14 | 232 | 4 | 9373155 | ||
| Pubmed | 1.83e-06 | 14 | 232 | 4 | 8022818 | ||
| Pubmed | MYH9 KMT2B DARS1 TRRAP NEK9 RTF1 FASN DST PAPOLA UTRN AIMP2 EP400 PAICS EIF4A1 CCT8 | 1.85e-06 | 506 | 232 | 15 | 30890647 | |
| Pubmed | MYH9 DARS1 TRIM21 FASN NCAPD2 ATP5PD WDR77 AIMP2 IPO7 NUP133 CCT8 CCAR2 | 1.88e-06 | 320 | 232 | 12 | 28685749 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH9 TBC1D9B CFTR DARS1 TRIM21 FASN UBR5 PGAM4 NCAPD2 ATP5PD IPO7 XPO4 PPP2R1A PPP2R1B CCT8 CCAR2 CTNNA1 | 1.94e-06 | 647 | 232 | 17 | 26618866 |
| Pubmed | MYH9 KMT2B TRIM21 SPTBN5 FASN SGSM2 AIMP2 PPFIA2 DUSP5 PDCD11 | 1.97e-06 | 214 | 232 | 10 | 22199357 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 ILK TRIM21 PARVB FASN PELO NCAPD2 IPO7 PPP2R1A PPP2R1B EIF4A1 CCT8 MACF1 CTNNA1 ATM CTNND1 | 2.20e-06 | 582 | 232 | 16 | 20467437 |
| Pubmed | MYH9 MAN2B1 TRIO RRBP1 TRRAP BIRC6 FASN DST UBR5 SYNE2 ATP5PD IPO7 RECQL FASTKD2 PAICS MYOF PPP2R1A EIF4A1 CCT8 PDCD11 MACF1 CCAR2 AKAP13 POFUT1 SNX1 | 2.24e-06 | 1297 | 232 | 25 | 33545068 | |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 3.01e-06 | 34 | 232 | 5 | 25925205 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 ILK DARS1 RRBP1 BIRC6 NEK9 RTF1 FASN PELO UBR5 SYNE2 NCAPD2 ATP5PD AIMP2 IPO7 RECQL PAICS PPP2R1A EIF4A1 CCT8 MACF1 CCAR2 AKAP13 CTNNA1 CTNND1 SNX1 | 3.29e-06 | 1415 | 232 | 26 | 28515276 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | LZTS3 TRIO SACS UBR5 RASAL2 IQSEC3 PPFIA2 GRIN2A PPP2R1A MACF1 AKAP11 | 3.36e-06 | 281 | 232 | 11 | 28706196 |
| Pubmed | USP34 ILK UBR5 NCAPD2 ANAPC5 IPO7 EP400 MACF1 CCAR2 AKAP11 CTNND1 | 3.48e-06 | 282 | 232 | 11 | 23667531 | |
| Pubmed | MYH9 TRIM21 TRRAP FASN CLPB UBR5 SYNE2 UGT2A1 DMD WDR77 RIPK3 IPO7 EP400 DYNC2H1 DNAH2 MYOF TTLL6 SNX1 | 3.68e-06 | 754 | 232 | 18 | 35906200 | |
| Pubmed | MYH9 MYO9B DARS1 RRBP1 NKRF SH3BP4 FASN PELO PAPOLA SVIL WDR77 CDC42BPG AIMP2 IPO7 DVL1 RECQL THOC6 MYOF PPP2R1A EIF4A1 CCT8 CTNNA1 CTNND1 ATP1A3 | 3.71e-06 | 1247 | 232 | 24 | 27684187 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH9 TRIM21 TRRAP DDB2 USP19 USP38 CLPB UBR5 PIK3CG UTRN RAD17 USP13 IPO7 DYNC2H1 USP43 FEM1B PPP2R1B KCTD3 CTNND1 USPL1 NACA4P | 4.48e-06 | 1005 | 232 | 21 | 19615732 |
| Pubmed | KMT2B TRRAP NEK9 NKRF FASN NCAPD2 EP400 DVL1 PAICS PPP2R1A RABEP1 CCT8 PDCD11 CTNND1 SNX1 | 4.95e-06 | 549 | 232 | 15 | 38280479 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH9 SH3BP4 C16orf89 FASN PKD1 PKHD1 AKR1B1 UTRN TOM1L2 DYNC2H1 PPFIA2 SUCNR1 SLC44A4 PPL SLC3A1 MYOF SLC12A1 ANO6 CEP250 CCT8 RAB15 | 5.29e-06 | 1016 | 232 | 21 | 19056867 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MYH9 ILK DARS1 USP19 FASN PELO SYNE2 NCAPD2 UTRN ATP5PD TMED1 RECQL PAICS PPL MYOF PPP2R1A PPP2R1B ANO6 EIF4A1 CCT8 PDCD11 CTNNA1 NGLY1 M6PR SNX1 | 5.59e-06 | 1367 | 232 | 25 | 32687490 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 MYH9 ILK PARVB RRBP1 TRRAP NEK9 AFAP1L1 SH3BP4 RTF1 PELO UBR5 AKR1B1 RASAL2 XPO4 PAICS PPP2R1A RABEP1 EIF4A1 NUP133 CCAR2 AKAP13 AKAP11 NACA4P | 6.05e-06 | 1284 | 232 | 24 | 17353931 |
| Pubmed | MYH9 DARS1 TRIM21 RRBP1 DST SVIL UTRN PAICS PPL RABEP1 MACF1 CTNNA1 | 6.26e-06 | 360 | 232 | 12 | 33111431 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYH9 TBC1D9B LZTS3 SLC22A17 PLEKHM1 TBC1D9 RALBP1 KCNN1 PPFIA2 GRIN2A PAICS NUP133 IPO13 CCAR2 USPL1 | 6.28e-06 | 560 | 232 | 15 | 21653829 |
| Pubmed | MYH9 MYO9A DARS1 RRBP1 EFR3A FASN DST NCAPD2 RASAL2 IPO7 PAICS PPP2R1A SLITRK5 CCT8 MACF1 CTNNA1 CTNND1 | 6.39e-06 | 708 | 232 | 17 | 39231216 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 DARS1 BIRC6 FASN PELO CLPB UBR5 NCAPD2 ANAPC5 ATP5PD IPO7 PAICS PPP2R1A EIF4A1 NUP133 | 7.91e-06 | 571 | 232 | 15 | 37167062 |
| Pubmed | 8.51e-06 | 151 | 232 | 8 | 17043677 | ||
| Pubmed | TRIO BIRC6 EFR3A PTPRK CASKIN2 SVIL SYNE2 DMD UTRN ATP5PD IPO7 GRAMD1A DUSP5 XPO4 PPP2R1A TBC1D31 KCTD3 NUP133 CCAR2 CTNNA1 CTNND1 | 8.58e-06 | 1049 | 232 | 21 | 27880917 | |
| Pubmed | MAN2B1 GON4L RRBP1 NKRF SH3BP4 FARP2 DST PSME4 CASKIN2 ANAPC5 RASAL2 CDC42BPG USP13 EIF4A1 AKAP13 HPS5 | 8.85e-06 | 650 | 232 | 16 | 38777146 | |
| Pubmed | MYH9 LZTS3 TRIO DARS1 RRBP1 BIRC6 NRXN1 ATP5PD IQSEC3 PPFIA2 GRAMD1A DVL1 GRIN2A NT5DC3 ARFGEF3 OSBP RABEP1 SLITRK5 CCT8 MACF1 CTNND1 SNX1 | 9.09e-06 | 1139 | 232 | 22 | 36417873 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 9.60e-06 | 256 | 232 | 10 | 33397691 | |
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 20661302 | ||
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 21198641 | ||
| Pubmed | MYH9 DARS1 RRBP1 BIRC6 TBC1D9 FASN UBR5 NCAPD2 ATP5PD WDR77 TMED1 IPO7 XPO4 PPP2R1A NUP133 IPO13 | 1.01e-05 | 657 | 232 | 16 | 36180527 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH9 DARS1 TRIM21 NEK9 FASN DST PELO UBR5 SVIL NCAPD2 AKR1B1 WDR77 TOM1L2 AIMP2 IPO7 RECQL PAICS PPP2R1A EIF4A1 CCT8 MACF1 CCAR2 | 1.04e-05 | 1149 | 232 | 22 | 35446349 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.17e-05 | 262 | 232 | 10 | 36880596 | |
| Pubmed | TRPM7 DARS1 TRRAP EFR3A RTF1 PELO NCAPD2 WDR77 POLE2 PPP2R1A TBC1D31 EIF4A1 CCT8 | 1.22e-05 | 451 | 232 | 13 | 30033366 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.51e-05 | 118 | 232 | 7 | 27377895 | |
| Pubmed | BIRC6 NEK9 USP19 FARP2 RTF1 UBR5 PEX16 WDR77 TOM1L2 USP13 POLE2 RECQL PPP2R1B RABEP1 NGLY1 | 1.53e-05 | 604 | 232 | 15 | 38803224 | |
| Pubmed | 1.60e-05 | 8 | 232 | 3 | 20215348 | ||
| Pubmed | 1.62e-05 | 216 | 232 | 9 | 31519766 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | DARS1 RRBP1 CLPB ATP5PD AIMP2 IPO7 RECQL PAICS PPL MYOF NT5DC2 NUP133 CCAR2 CTNNA1 CTNND1 | 1.62e-05 | 607 | 232 | 15 | 39147351 |
| Pubmed | 1.69e-05 | 120 | 232 | 7 | 27320910 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | NPSR1 PTDSS2 SLC22A17 DST SACS ABCC8 PKD1 PEX16 SGSM3 AKR1B1 TMED1 FOLR1 GRAMD1A DNAJC14 IPO13 CTNNA1 | 2.08e-05 | 697 | 232 | 16 | 28298427 |
| Pubmed | GON4L USP19 UBR5 SGSM2 MCF2L IQSEC3 EP400 FEM1B ARFGEF3 MROH1 MACF1 CCAR2 | 2.12e-05 | 407 | 232 | 12 | 12693553 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH9 MAN2B1 DARS1 TRRAP BIRC6 FASN PGAM4 IPO7 MYOF HELZ2 CCT8 | 2.24e-05 | 344 | 232 | 11 | 30333137 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | MYH9 PLEKHM1 FASN PELO WDR77 IPO7 PAICS PPP2R1A PPP2R1B CCT8 CCAR2 | 2.24e-05 | 344 | 232 | 11 | 36282215 |
| Pubmed | 2.39e-05 | 9 | 232 | 3 | 12672969 | ||
| Pubmed | DST SACS TOM1L2 IQSEC3 RASGRF1 PPFIA2 HCN3 GRIN2A MACF1 CTNNA1 CTNND1 | 2.43e-05 | 347 | 232 | 11 | 17114649 | |
| Pubmed | HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells. | 2.55e-05 | 52 | 232 | 5 | 26643866 | |
| Pubmed | MYH9 DARS1 FASN NCAPD2 IPO7 RECQL PAICS PPP2R1A EIF4A1 NUP133 CCT8 PDCD11 CTNND1 | 2.55e-05 | 484 | 232 | 13 | 31995728 | |
| Interaction | FGD5 interactions | MYH9 CFTR DARS1 RRBP1 TRRAP FASN DST SVIL UTRN PAICS CCT8 MACF1 AKAP11 | 7.90e-07 | 207 | 230 | 13 | int:FGD5 |
| Interaction | TOP3B interactions | USP34 TBC1D9B KMT2B MAN2B1 TRIO MYO9B DARS1 PARVB TTC3 TRRAP BIRC6 LYST PLEKHM1 ACOX3 TBC1D9 HIRA SH3BP4 FASN DST PSME4 SGSM2 SVIL PKD1 NCAPD2 MCF2L EP400 RASA3 DUSP5 DVL1 CCNF MYOF MROH1 DNAJC14 EIF4A1 HELZ2 PDCD11 AKAP13 POFUT1 | 1.72e-06 | 1470 | 230 | 38 | int:TOP3B |
| Interaction | CCDC8 interactions | MYO9B DARS1 MYO5C FASN DST SACS UBR5 SVIL UTRN ATP5PD IPO7 EP400 CCNF PPP2R1A DNAH12 EIF4A1 CEP250 CCT8 PDCD11 MACF1 CCAR2 CTNNA1 CTNND1 | 1.96e-06 | 656 | 230 | 23 | int:CCDC8 |
| Interaction | ATOH1 interactions | 3.64e-06 | 80 | 230 | 8 | int:ATOH1 | |
| Interaction | RHOV interactions | ILK TRPM7 MYO9A SH3BP4 EFR3A DST RASAL2 CDC42BPG RASA3 FASTKD2 MYOF SLITRK5 CTNND1 | 4.69e-06 | 243 | 230 | 13 | int:RHOV |
| Interaction | SIRT7 interactions | USP34 MYH9 TRRAP BIRC6 NKRF FASN DST UBR5 SYNE2 NCAPD2 UTRN WDR77 IPO7 RECQL PAICS PPP2R1A EIF4A1 HELZ2 NUP133 PDCD11 MACF1 CCAR2 CTNNA1 ATM | 4.86e-06 | 744 | 230 | 24 | int:SIRT7 |
| Interaction | MCM2 interactions | MYH9 MYO9A MYO9B ACOX1 CFTR DARS1 TRRAP SLC22A17 HIRA RTF1 FASN DST CLPB UBR5 DMD UTRN IPO7 EP400 FASTKD2 PAICS CCNF PPP2R1A NT5DC2 EIF4A1 CCT8 MACF1 CTNNA1 ATM CTNND1 SNX1 | 6.20e-06 | 1081 | 230 | 30 | int:MCM2 |
| Interaction | HDAC1 interactions | MYH9 KMT2B TRPM7 KDM5C GON4L TRIM21 BIRC6 DDB2 NEK9 USP19 FASN DST USP38 PAPOLA UBR5 RALBP1 SYNE2 NCAPD2 UTRN EP400 DVL1 USP43 CCNF PPP2R1A PPP2R1B RABEP1 CEP250 CCT8 CCAR2 ATM | 1.00e-05 | 1108 | 230 | 30 | int:HDAC1 |
| Interaction | NUP43 interactions | USP34 KMT2B KDM5C TSPYL2 GON4L NKRF RTF1 DST PELO UBR5 SYNE2 EP400 DVL1 XPC PPP2R1A CEP250 NUP133 CCT8 PDCD11 CCAR2 HPS5 | 1.07e-05 | 625 | 230 | 21 | int:NUP43 |
| Interaction | HSPA2 interactions | ILK ACOX1 CFTR RRBP1 MYO5C RTF1 PAPOLA CLPB NOS2 RASAL2 AIMP2 GK5 CCNF CEP250 KCTD3 RAB15 SNX1 | 1.31e-05 | 440 | 230 | 17 | int:HSPA2 |
| Interaction | YWHAZ interactions | MYH9 TRPM7 MYO9A CFTR TRIM21 PITPNC1 LYST SH3BP4 DST NRXN1 SVIL SYNE2 AKR1B1 NOS2 RASAL2 CDC42BPG AIMP2 IPO7 RASGRF1 FOLR1 PPFIA2 USP43 SLC3A1 CCNF PPP2R1A RABEP1 MACF1 CCAR2 AKAP13 AKAP11 PLEKHM3 ATM CTNND1 | 1.77e-05 | 1319 | 230 | 33 | int:YWHAZ |
| Interaction | DEF8 interactions | 2.43e-05 | 51 | 230 | 6 | int:DEF8 | |
| Interaction | LRRC31 interactions | KNTC1 MYH9 TRIO MYO9B RRBP1 MYO5C FASN NCAPD2 IPO7 MYOF AKAP13 | 2.48e-05 | 205 | 230 | 11 | int:LRRC31 |
| Interaction | MTNR1B interactions | 2.53e-05 | 135 | 230 | 9 | int:MTNR1B | |
| Interaction | UGT2B15 interactions | 2.86e-05 | 6 | 230 | 3 | int:UGT2B15 | |
| Interaction | DMD interactions | 3.56e-05 | 141 | 230 | 9 | int:DMD | |
| Interaction | ACTN1 interactions | MYH9 KDM5C CFTR TRIM21 NRXN1 UBR5 SVIL PKD1 WDR77 RECQL GRIN2A CCNF PPP2R1A CTNNA1 | 4.01e-05 | 341 | 230 | 14 | int:ACTN1 |
| Interaction | CRYL1 interactions | 4.17e-05 | 56 | 230 | 6 | int:CRYL1 | |
| Interaction | CDC42 interactions | ILK TRIO TRPM7 MYO9A MYO9B CFTR RRBP1 TRRAP SH3BP4 EFR3A SYNE2 NCAPD2 MCF2L AKR1B1 UTRN ATP5PD RASAL2 CDC42BPG RASA3 DYNC2H1 RFX6 FASTKD2 CCNF ARFGEF3 MYOF PPP2R1A ANO6 NT5DC2 KCTD3 SLITRK5 CTNNA1 CTNND1 | 4.63e-05 | 1323 | 230 | 32 | int:CDC42 |
| Interaction | FBXO22 interactions | KDM5C TRIM21 RRBP1 USP9Y TRRAP IGHV3-64D RTF1 NCAPD2 PHOX2B RECQL PAICS CCNF PPP2R1A DNAH12 CTNNA1 ATM CTNND1 NACA4P | 5.15e-05 | 540 | 230 | 18 | int:FBXO22 |
| Interaction | RHOQ interactions | ILK TRPM7 SH3BP4 EFR3A DST PTPRK CASKIN2 UTRN RASAL2 CDC42BPG ARFGEF3 MYOF PPP2R1A SLITRK5 CTNNA1 CTNND1 | 5.18e-05 | 442 | 230 | 16 | int:RHOQ |
| Interaction | FAM43A interactions | 5.24e-05 | 36 | 230 | 5 | int:FAM43A | |
| Interaction | PRICKLE2 interactions | 7.46e-05 | 62 | 230 | 6 | int:PRICKLE2 | |
| Interaction | DQX1 interactions | 8.49e-05 | 21 | 230 | 4 | int:DQX1 | |
| Interaction | CRY1 interactions | 1.05e-04 | 162 | 230 | 9 | int:CRY1 | |
| Interaction | RHOA interactions | ILK TRIO TRPM7 MYO9A MYO9B CFTR RRBP1 TRRAP SH3BP4 EFR3A CLPB PTPRK SYNE2 MCF2L UTRN RASAL2 RASGRF1 GRAMD1A GPAT3 FASTKD2 MYOF ANO6 SLITRK5 PDCD11 MACF1 AKAP13 CTNNA1 CTNND1 SNX1 | 1.09e-04 | 1199 | 230 | 29 | int:RHOA |
| Interaction | CIT interactions | MYH9 ILK MYO9B DARS1 PARVB TTC3 TRRAP BIRC6 NKRF FASN PELO CLPB PIK3CG SVIL SYNE2 DDX60L ATP5PD RASAL2 IPO7 EP400 DYNC2H1 RECQL PPP2R1A DNAH12 EIF4A1 NUP133 CCT8 PDCD11 MACF1 CCAR2 CTNNA1 CTNND1 NACA4P | 1.12e-04 | 1450 | 230 | 33 | int:CIT |
| Interaction | PNKD interactions | 1.39e-04 | 132 | 230 | 8 | int:PNKD | |
| Interaction | PSMC5 interactions | MYH9 CFTR TRIM21 BIRC6 PSME4 RALBP1 BFSP2 NOS2 WDR77 AIMP2 RECQL XPC CCNF PPP2R1A CCT8 CCAR2 | 1.49e-04 | 484 | 230 | 16 | int:PSMC5 |
| Interaction | LGALS9 interactions | MYH9 MAN2B1 CFTR DARS1 PTGFRN FASN PTPRK NCAPD2 IPO7 RECQL PAICS PPP2R1A ANO6 EIF4A1 NUP133 CCT8 PDCD11 CTNND1 | 1.51e-04 | 588 | 230 | 18 | int:LGALS9 |
| Interaction | GAN interactions | TRIM21 TRRAP SPTBN5 DST SYNE2 PKD1 DMD WDR77 DYNC2H1 EIF4A1 CCT8 | 1.64e-04 | 253 | 230 | 11 | int:GAN |
| Interaction | XPO4 interactions | 1.70e-04 | 102 | 230 | 7 | int:XPO4 | |
| Interaction | C1orf115 interactions | 1.73e-04 | 25 | 230 | 4 | int:C1orf115 | |
| Interaction | HUWE1 interactions | USP34 MYH9 CFTR DARS1 TTC3 BIRC6 NEK9 FASN PELO PAPOLA CLPB UBR5 NCAPD2 ANAPC5 NOS2 ATP5PD IPO7 DVL1 PAICS CCNF EIF4A1 CEP250 HELZ2 NUP133 CCT8 MACF1 ATM | 1.74e-04 | 1110 | 230 | 27 | int:HUWE1 |
| Interaction | ZUP1 interactions | 1.80e-04 | 174 | 230 | 9 | int:ZUP1 | |
| Interaction | VTA1 interactions | 1.80e-04 | 137 | 230 | 8 | int:VTA1 | |
| Interaction | CTNNA1 interactions | ILK CFTR FASN PKD1 DMD UTRN DVL1 OSBP EIF4A1 CCT8 MACF1 CTNNA1 CTNND1 | 1.88e-04 | 347 | 230 | 13 | int:CTNNA1 |
| Interaction | YWHAQ interactions | MYH9 TRPM7 MYO9A CFTR TRIM21 LYST SH3BP4 FASN DST NRXN1 CLPB SVIL NOS2 WDR77 RASAL2 AIMP2 USP43 DNAH7 CCNF RABEP1 CEP250 MACF1 CCAR2 AKAP13 AKAP11 PLEKHM3 CTNND1 | 1.95e-04 | 1118 | 230 | 27 | int:YWHAQ |
| Interaction | CDH1 interactions | MYH9 ILK CFTR EFR3A FARP2 FASN DST CASKIN2 SVIL PKD1 UTRN CCS RAD17 USP43 PAICS PPL CCT8 MACF1 CTNNA1 CTNND1 SNX1 | 2.04e-04 | 768 | 230 | 21 | int:CDH1 |
| Interaction | UTRN interactions | 2.04e-04 | 217 | 230 | 10 | int:UTRN | |
| Interaction | EPB41L4A interactions | 2.09e-04 | 140 | 230 | 8 | int:EPB41L4A | |
| Interaction | RAC1 interactions | MYH9 ILK TRIO TRPM7 SH3BP4 EFR3A FASN DST CASKIN2 RALBP1 MCF2L UTRN NOS2 RASAL2 CDC42BPG IPO7 RASGRF1 RASA3 DVL1 MYOF ANO6 SLITRK5 MACF1 CTNNA1 CTNND1 ATP1A3 | 2.12e-04 | 1063 | 230 | 26 | int:RAC1 |
| Interaction | YWHAG interactions | TRPM7 MYO9A CFTR TRIM21 PITPNC1 TRRAP LYST AFAP1L1 SH3BP4 FARP2 DST CASKIN2 SVIL SYNE2 UTRN NOS2 CCS RASAL2 USP43 DNAH7 CCNF PPP2R1A RABEP1 CEP250 MACF1 AKAP13 AKAP11 PLEKHM3 CTNND1 | 2.15e-04 | 1248 | 230 | 29 | int:YWHAG |
| Interaction | ACTN4 interactions | MYH9 CFTR TRIM21 MYO5C NRXN1 SACS UBR5 SVIL UTRN NOS2 FOLR1 CCNF OSBP SERPINE1 | 2.16e-04 | 400 | 230 | 14 | int:ACTN4 |
| Interaction | LMBR1L interactions | TBC1D9B CFTR PTDSS2 PTGFRN USP19 FASN PELO PTPRK UBR5 NCAPD2 ANAPC5 TOM1L2 IPO7 DYNC2H1 GRAMD1A DNAH2 ARFGEF3 PPP2R1A RABEP1 EIF4A1 NUP133 POFUT1 CTNNA1 ATP1A3 | 2.20e-04 | 946 | 230 | 24 | int:LMBR1L |
| Interaction | PGM5 interactions | 2.26e-04 | 11 | 230 | 3 | int:PGM5 | |
| Interaction | HERC2 interactions | MYO9B TTC3 BIRC6 USP19 FARP2 DST SYNE2 GRIN2A PPL THOC6 CCNF RABEP1 CEP250 MACF1 CTNNA1 HPS5 | 2.29e-04 | 503 | 230 | 16 | int:HERC2 |
| Interaction | PPP2R1A interactions | MYH9 CFTR EFR3A RTF1 FASN NCAPD2 NOS2 AIMP2 EP400 PPFIA2 GRIN2A THOC6 SLC6A2 CCNF PPP2R1A PPP2R1B EIF4A1 CCAR2 ATM | 2.38e-04 | 665 | 230 | 19 | int:PPP2R1A |
| Interaction | PIP interactions | 2.42e-04 | 181 | 230 | 9 | int:PIP | |
| Interaction | C11orf52 interactions | TRIO SH3BP4 EFR3A FARP2 DST CASKIN2 UTRN RASAL2 RASA3 MACF1 CTNNA1 CTNND1 | 2.53e-04 | 311 | 230 | 12 | int:C11orf52 |
| Interaction | PFN1 interactions | KNTC1 MYH9 TRIO MYO9A MYO9B CFTR TRIM21 BIRC6 MYO5C FASN SYNE2 FOLR1 CCNF RABEP1 MACF1 AKAP13 | 2.62e-04 | 509 | 230 | 16 | int:PFN1 |
| Interaction | RHOF interactions | ILK TRPM7 MYO9B PARVB SH3BP4 EFR3A CASKIN2 NCAPD2 UTRN RASAL2 IPO7 RASA3 FASTKD2 MYOF PPP2R1A ANO6 SLITRK5 MACF1 CTNNA1 | 2.77e-04 | 673 | 230 | 19 | int:RHOF |
| Cytoband | 15q21 | 2.04e-05 | 11 | 232 | 3 | 15q21 | |
| GeneFamily | Ubiquitin specific peptidases | 8.68e-07 | 56 | 169 | 7 | 366 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | PLEKHM1 AFAP1L1 FARP2 MCF2L RASAL2 CDC42BPG RASGRF1 RASA3 OSBP AKAP13 PLEKHM3 | 3.86e-06 | 206 | 169 | 11 | 682 |
| GeneFamily | EF-hand domain containing|Plakins | 4.34e-05 | 8 | 169 | 3 | 939 | |
| GeneFamily | Myosins, class IX | 8.69e-05 | 2 | 169 | 2 | 1103 | |
| GeneFamily | Protein phosphatase 2 scaffold subunits|STRIPAK complex | 8.69e-05 | 2 | 169 | 2 | 1266 | |
| GeneFamily | ATP binding cassette subfamily C | 2.14e-04 | 13 | 169 | 3 | 807 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 2.14e-04 | 13 | 169 | 3 | 1146 | |
| GeneFamily | Small G protein signaling modulators | 2.59e-04 | 3 | 169 | 2 | 751 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.79e-04 | 66 | 169 | 5 | 722 | |
| GeneFamily | Dyneins, axonemal | 4.95e-04 | 17 | 169 | 3 | 536 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.31e-03 | 51 | 169 | 4 | 870 | |
| GeneFamily | Transient receptor potential cation channels | 2.21e-03 | 28 | 169 | 3 | 249 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 2.34e-03 | 8 | 169 | 2 | 1125 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.45e-03 | 29 | 169 | 3 | 396 | |
| GeneFamily | WD repeat domain containing | 3.29e-03 | 262 | 169 | 8 | 362 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 3.72e-03 | 10 | 169 | 2 | 830 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 TRIO MYO9B TRRAP HIRA EFR3A HOXB2 DST PSME4 PTPRK SACS UBR5 SYNE2 DMD USP13 IPO7 DUSP5 KIFAP3 MYOF TBC1D31 SERPINE1 NUP133 MACF1 AKAP13 AKAP11 | 1.63e-07 | 856 | 230 | 25 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KNTC1 KMT2B MYO9B PITPNC1 BIRC6 FASN PIK3CG NCAPD2 UTRN MACF1 ATM | 6.01e-07 | 180 | 230 | 11 | M8239 |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 2.24e-06 | 166 | 230 | 10 | M9015 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 3.02e-06 | 71 | 230 | 7 | M2948 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KNTC1 MYH9 TRIO MYO9B DST RALBP1 RASAL2 KIFAP3 CEP250 AKAP13 | 1.12e-05 | 199 | 230 | 10 | M5893 |
| Coexpression | GSE6875_WT_VS_FOXP3_KO_TREG_DN | 1.12e-05 | 199 | 230 | 10 | M6804 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP34 TBC1D9B TSPYL2 DARS1 PARVB TTC3 LYST EFR3A FASN DST ABCC8 SYNE2 SCAPER UTRN RAD17 IPO7 RASGRF1 XPC PPL RABEP1 RAB15 AKAP11 | 3.39e-05 | 946 | 230 | 22 | M39169 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 3.82e-05 | 184 | 230 | 9 | M9005 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | LZTS3 PITPNC1 TTC3 LYST TBC1D9 NRXN1 NALCN PTPRK ANKAR MCF2L RASAL2 AKAP6 ADAMTS3 PPFIA2 HCN3 NT5DC3 GK5 ARFGEF3 KIFAP3 SLITRK5 ATP1A3 HBE1 CDH4 SNX1 | 4.44e-05 | 1106 | 230 | 24 | M39071 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | USP34 LYRM9 TBC1D9B MYO9B ACOX1 TRPM2 ACOX3 DGLUCY CASKIN2 SVIL SYNE2 SGSM3 RECQL CEP250 AKAP13 CTNND1 | 4.54e-05 | 567 | 230 | 16 | M16909 |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_UP | 5.36e-05 | 149 | 230 | 8 | M393 | |
| Coexpression | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 5.39e-05 | 9 | 230 | 3 | M14105 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_DN | 5.99e-05 | 195 | 230 | 9 | M4652 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP | 7.00e-05 | 199 | 230 | 9 | M9419 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN | 7.28e-05 | 200 | 230 | 9 | M9373 | |
| Coexpression | GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP | 7.28e-05 | 200 | 230 | 9 | M3529 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 7.28e-05 | 200 | 230 | 9 | M7518 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.05e-04 | 164 | 230 | 8 | M19957 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | LZTS3 INHBA LYST HIRA DST NRXN1 ABCC8 PKD1 MCF2L TOM1L2 RFX6 NT5DC3 ARFGEF3 | 1.17e-04 | 429 | 230 | 13 | M45694 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KMT2B LZTS3 INHBA MYO9A TSPYL2 GON4L LYST PLEKHM1 DST PELO RNF103 PKD1 RASAL2 DUSP5 PPL FEM1B OSBP RABEP1 USPL1 | 1.28e-04 | 822 | 230 | 19 | M6782 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.35e-04 | 217 | 230 | 9 | M16407 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 ODAD1 SYNE2 DMD AKAP6 DYNC2H1 DNAH2 USP43 DNAH7 DNAH12 TTLL6 CFAP46 | 5.82e-10 | 197 | 232 | 12 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | USP34 TRIO PARVB BIRC6 DST UBR5 SYNE2 MCF2L UTRN MACF1 CTNND1 | 8.92e-09 | 200 | 232 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-08 | 192 | 232 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | CFTR TSPYL2 RRBP1 FAAH MYO5C C16orf89 FASN SYNE2 SCAPER ARFGEF3 | 9.08e-08 | 197 | 232 | 10 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 ODAD1 CCDC13 DYNC2H1 DNAH2 USP43 DNAH7 DNAH12 CFAP46 | 2.69e-07 | 169 | 232 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.38e-07 | 179 | 232 | 9 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 ODAD1 DYNC2H1 DNAH2 USP43 SLC44A4 DNAH7 DNAH12 CFAP46 | 4.59e-07 | 180 | 232 | 9 | 92fb01b91261b3103454924cde56add337b41844 |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.59e-07 | 135 | 232 | 8 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP251 ODAD1 CCDC13 AKAP6 DYNC2H1 DNAH2 DNAH7 DNAH12 CFAP46 | 5.77e-07 | 185 | 232 | 9 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.90e-07 | 189 | 232 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 191 | 232 | 9 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 ODAD1 AKAP6 DYNC2H1 DNAH2 SLC44A4 DNAH7 DNAH12 CFAP46 | 8.58e-07 | 194 | 232 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | CFAP251 PTPRK SYNE2 DYNC2H1 SLC44A4 DNAH7 ARFGEF3 DNAH12 CFAP46 | 8.96e-07 | 195 | 232 | 9 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.75e-07 | 197 | 232 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 ODAD1 UGT2A1 HSD17B13 SLC44A4 GK5 DNAH7 DNAH12 CFAP46 | 1.02e-06 | 198 | 232 | 9 | d0ecace1fad24ce50b0935036fabb07e6c9e372d |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | LZTS3 RRBP1 FAAH C16orf89 SPTBN5 ABCC8 HSD17B13 UTRN CDC42BPG | 1.06e-06 | 199 | 232 | 9 | 121de4e02585de3a3010398387c523bacf8ce546 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-06 | 200 | 232 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-06 | 108 | 232 | 7 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-06 | 161 | 232 | 8 | 9cfbbcd38ec2e75376bbc26001964b6991ad0e21 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-06 | 170 | 232 | 8 | 985c2d5962100fab0d95bee39f382ccbe799331e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 176 | 232 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-06 | 178 | 232 | 8 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.83e-06 | 180 | 232 | 8 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.46e-06 | 183 | 232 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.46e-06 | 183 | 232 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.68e-06 | 184 | 232 | 8 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 187 | 232 | 8 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 187 | 232 | 8 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 187 | 232 | 8 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-06 | 187 | 232 | 8 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 187 | 232 | 8 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 187 | 232 | 8 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.91e-06 | 189 | 232 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.91e-06 | 189 | 232 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.18e-06 | 190 | 232 | 8 | 0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 190 | 232 | 8 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 190 | 232 | 8 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.18e-06 | 190 | 232 | 8 | 11fbd4e9f02750354b3aadf30edc991f8d4f8f41 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.18e-06 | 190 | 232 | 8 | 148d43dd72e2e22b2cd68e17fedae6bd98b32aee | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.18e-06 | 190 | 232 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 190 | 232 | 8 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.18e-06 | 190 | 232 | 8 | 2724e8f375d8d9f5f2a77444e0491af264babac5 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 7.47e-06 | 191 | 232 | 8 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 191 | 232 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.47e-06 | 191 | 232 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 191 | 232 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM1|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.47e-06 | 191 | 232 | 8 | bd641aab36276dd952a7265ee79ba455b38d8e6b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.47e-06 | 191 | 232 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 7.47e-06 | 191 | 232 | 8 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-06 | 192 | 232 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.06e-06 | 193 | 232 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.06e-06 | 193 | 232 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 8.06e-06 | 193 | 232 | 8 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.06e-06 | 193 | 232 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.09e-06 | 138 | 232 | 7 | 76be06136c83c167cedece7515228ed4d29dd1f0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.37e-06 | 194 | 232 | 8 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.37e-06 | 194 | 232 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.69e-06 | 195 | 232 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.69e-06 | 195 | 232 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.69e-06 | 195 | 232 | 8 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.69e-06 | 195 | 232 | 8 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 9.01e-06 | 196 | 232 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.36e-06 | 197 | 232 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-06 | 197 | 232 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.71e-06 | 198 | 232 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.71e-06 | 198 | 232 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 9.71e-06 | 198 | 232 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.71e-06 | 198 | 232 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 232 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 199 | 232 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-05 | 199 | 232 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 232 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 199 | 232 | 8 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 232 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-05 | 200 | 232 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.04e-05 | 200 | 232 | 8 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 2.38e-05 | 163 | 232 | 7 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-05 | 169 | 232 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-05 | 173 | 232 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 174 | 232 | 7 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 3.75e-05 | 175 | 232 | 7 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 3.75e-05 | 175 | 232 | 7 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 176 | 232 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 176 | 232 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | TRIM21 TRRAP NEK9 SLC35D1 UBR5 SYNE2 RASAL2 EP400 MYOF MACF1 AKAP11 ATM | 5.71e-07 | 191 | 229 | 12 | 4168_DN |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | TBC1D9 SGSM2 KCNN1 SGSM3 RASAL2 DNAH7 SLC3A1 CCNF RABEP1 CEP250 AKAP13 HBE1 | 7.12e-07 | 195 | 229 | 12 | 5093_DN |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | USP34 TRIO MYO9B PTDSS2 RRBP1 HIRA DYNC2H1 ZNF783 FEM1B PPP2R1B RABEP1 MACF1 | 8.83e-07 | 199 | 229 | 12 | 3403_DN |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | INHBA TRIM21 SLC35D1 SPINK4 PAPOLA C5AR1 ANAPC5 RASAL2 DYNC2H1 SLC3A1 ATP1A3 | 5.07e-06 | 196 | 229 | 11 | 4699_UP |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | USP34 GON4L RRBP1 PAPOLA CASKIN2 FOLR1 ZNF783 MYOF IPO13 CTNND1 SNX1 | 5.33e-06 | 197 | 229 | 11 | 4998_DN |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | USP34 INHBA TRIM21 RRBP1 RTF1 SVIL MCF2L RASAL2 RASA3 MYOF POFUT1 | 5.33e-06 | 197 | 229 | 11 | 3225_DN |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | MYO9B KDM5C PTDSS2 PARVB PAPOLA SCAPER SGSM3 FEM1B PPP2R1B IPO13 MACF1 | 5.33e-06 | 197 | 229 | 11 | 5482_DN |
| Drug | AC1L3NEP | 5.46e-06 | 26 | 229 | 5 | CID000092096 | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | INHBA NEK9 HIRA SGSM3 ANAPC5 UTRN CCS DYNC2H1 MYOF CEP250 POFUT1 | 5.87e-06 | 199 | 229 | 11 | 3079_DN |
| Drug | plakin | 1.90e-05 | 82 | 229 | 7 | CID000018752 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.73e-05 | 193 | 229 | 10 | 3667_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | KMT2B ZNF268 KDM5C PTDSS2 SGSM3 RECQL PPP2R1B RABEP1 ATM HPS5 | 2.73e-05 | 193 | 229 | 10 | 6931_DN |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | GON4L HIRA FARP2 CASKIN2 SCAPER SGSM3 FASTKD2 FEM1B ATM HBE1 | 2.86e-05 | 194 | 229 | 10 | 5776_DN |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | TRPM2 PTDSS2 HOXA2 SLC35D1 NT5DC3 CCNF MYOF RABEP1 CEP250 AKAP13 | 2.98e-05 | 195 | 229 | 10 | 1214_DN |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | TBC1D9B LZTS3 SLC35D1 UBR5 SVIL UTRN TRMT12 AKAP13 AKAP11 ATM | 3.12e-05 | 196 | 229 | 10 | 7139_DN |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | LZTS3 MYO9B USP19 PAPOLA SCAPER PEX16 SERHL2 FOLR1 PAICS CEP250 | 3.12e-05 | 196 | 229 | 10 | 3327_DN |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | USP34 TBC1D9B KMT2B RRBP1 SLC35D1 SCAPER DYNC2H1 XPC MYOF MACF1 | 3.12e-05 | 196 | 229 | 10 | 1174_DN |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | USP34 TRIO ACOX1 RRBP1 SPINK4 PAPOLA ANAPC5 PPP2R1B AKAP13 POFUT1 | 3.12e-05 | 196 | 229 | 10 | 4844_DN |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | MYO9B RRBP1 SGSM2 MCF2L TMED1 MYOF PPP2R1B AKAP13 POFUT1 ATM | 3.12e-05 | 196 | 229 | 10 | 4793_DN |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | LZTS3 TRIM21 SLC22A17 HIRA SLC35D1 CASKIN2 SCAPER UTRN EP400 SLC3A1 | 3.12e-05 | 196 | 229 | 10 | 5636_DN |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A | 3.12e-05 | 196 | 229 | 10 | 1790_DN | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 3.26e-05 | 197 | 229 | 10 | 362_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.26e-05 | 197 | 229 | 10 | 2747_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 3.26e-05 | 197 | 229 | 10 | 2059_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | TBC1D9B MYO9A ZNF268 GON4L ACOX3 FAAH HIRA CASKIN2 CEP250 ATM | 3.26e-05 | 197 | 229 | 10 | 1674_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | MYO9B KDM5C TRIM21 RRBP1 USP19 HIRA SVIL SCAPER MACF1 AKAP13 | 3.40e-05 | 198 | 229 | 10 | 2364_DN |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.40e-05 | 198 | 229 | 10 | 2062_DN | |
| Drug | 4-hydroxyderricin | 3.41e-05 | 7 | 229 | 3 | CID006438503 | |
| Drug | tamibarotene | ILK KMT2B TRIO TTC3 TRRAP NKRF HIRA DST PAPOLA SACS PIK3CG NOS2 USP13 DVL1 CCNF PPP2R1B MACF1 ATP1A3 | 3.65e-05 | 596 | 229 | 18 | ctd:C061133 |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A | TBC1D9B KDM5C RRBP1 SLC22A17 SGSM2 RECQL SLITRK5 AKAP13 POFUT1 SNX1 | 3.70e-05 | 200 | 229 | 10 | 6284_DN |
| Drug | S-(-)-Etomoxir | 6.88e-05 | 100 | 229 | 7 | CID000060765 | |
| Drug | AZFd | 7.60e-05 | 23 | 229 | 4 | CID000196489 | |
| Drug | 6-fluorocholesterol | 1.01e-04 | 2 | 229 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 1.01e-04 | 2 | 229 | 2 | CID006454807 | |
| Drug | 7-tricosene | 1.01e-04 | 2 | 229 | 2 | CID006365493 | |
| Drug | furosemide | CFTR TSPYL2 CLCN1 BFSP2 PAICS ABCC6 PPL SLC6A2 SLC12A1 SERPINE1 ATP1A3 | 1.04e-04 | 272 | 229 | 11 | CID000003440 |
| Drug | iotrolan | 1.14e-04 | 10 | 229 | 3 | CID000003738 | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 1.37e-04 | 190 | 229 | 9 | 622_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 1.42e-04 | 191 | 229 | 9 | 4647_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.48e-04 | 192 | 229 | 9 | 2335_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 3262_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.54e-04 | 193 | 229 | 9 | 2366_DN | |
| Drug | 4-cpp | 1.56e-04 | 11 | 229 | 3 | CID000018703 | |
| Drug | tetracosane | 1.56e-04 | 11 | 229 | 3 | CID000012592 | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; MCF7; HT_HG-U133A | TBC1D9B MYO9B PTDSS2 PAPOLA CASKIN2 SGSM2 NT5DC3 IPO13 PDCD11 | 1.60e-04 | 194 | 229 | 9 | 7469_DN |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 2430_DN | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | INHBA PTDSS2 PARVB HOXB2 CASKIN2 ADAMTS12 MYOF AKAP13 POFUT1 | 1.60e-04 | 194 | 229 | 9 | 4951_UP |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 1699_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 4648_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.60e-04 | 194 | 229 | 9 | 7098_DN | |
| Drug | wortmannin; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.66e-04 | 195 | 229 | 9 | 911_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; HL60; HG-U133A | 1.66e-04 | 195 | 229 | 9 | 1409_UP | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 5618_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 5021_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; HL60; HG-U133A | 1.66e-04 | 195 | 229 | 9 | 1726_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.66e-04 | 195 | 229 | 9 | 2359_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | NEK9 SLC22A17 USP19 SPINK4 PAPOLA SCAPER SERHL2 ZNF783 POFUT1 | 1.66e-04 | 195 | 229 | 9 | 6098_DN |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4974_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 2367_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | TBC1D9 SGSM2 SCAPER UTRN ADAMTS3 ZNF783 FEM1B RABEP1 SERPINE1 | 1.73e-04 | 196 | 229 | 9 | 4619_DN |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4965_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 5669_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 7124_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A | 1.73e-04 | 196 | 229 | 9 | 1440_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; HL60; HG-U133A | 1.73e-04 | 196 | 229 | 9 | 2023_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.73e-04 | 196 | 229 | 9 | 4747_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 6700_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 4606_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 5537_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 2788_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 3070_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 6466_DN | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | MYO9B TSPYL2 PTDSS2 RRBP1 SLC35D1 DGLUCY SCAPER TRMT12 KIFAP3 | 1.80e-04 | 197 | 229 | 9 | 1145_DN |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 6258_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 2544_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 4135_UP | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 197 | 229 | 9 | 6099_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 7384_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 1468_UP | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 1.87e-04 | 198 | 229 | 9 | 889_DN | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A | SLC35D1 SPTBN5 SPINK4 SCAPER C5AR1 UTRN SERHL2 PPP2R1B SERPINE1 | 1.87e-04 | 198 | 229 | 9 | 4363_UP |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 5983_DN | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 5993_UP | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 3450_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 3356_UP | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.87e-04 | 198 | 229 | 9 | 3129_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; HL60; HG-U133A | 1.87e-04 | 198 | 229 | 9 | 2008_DN | |
| Drug | AC1L9LMC | 1.92e-04 | 83 | 229 | 6 | CID000448113 | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 5927_UP | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 4390_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 7128_DN | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; HL60; HG-U133A | 1.94e-04 | 199 | 229 | 9 | 412_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | MYO9B TSPYL2 SLC22A17 SLC35D1 SGSM2 ZNF783 SLC3A1 MYOF AKAP13 | 1.94e-04 | 199 | 229 | 9 | 1509_DN |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 4831_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 6324_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 3203_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A | 1.94e-04 | 199 | 229 | 9 | 2046_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 229 | 9 | 6214_DN | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.01e-04 | 200 | 229 | 9 | 7167_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 2.01e-04 | 200 | 229 | 9 | 1165_DN | |
| Disease | Intellectual Disability | TRIO KDM5C GON4L TRRAP FASN NRXN1 SACS SCAPER AKAP6 IQSEC3 FOLR1 PPP2R1A MACF1 | 4.37e-05 | 447 | 225 | 13 | C3714756 |
| Disease | blood urea nitrogen measurement | GON4L PITPNC1 DDB2 SLC35D1 USP38 PIK3CG PKHD1 DMD RAD17 WDR72 PPFIA2 AKAP13 HPS5 | 4.89e-05 | 452 | 225 | 13 | EFO_0004741 |
| Disease | lung carcinoma, asbestos exposure measurement | 5.79e-05 | 2 | 225 | 2 | EFO_0001071, EFO_0004806 | |
| Disease | testosterone measurement | INHBA MYO9B TRPM2 BIRC6 FARP2 FASN NRXN1 FAM186A SYNE2 UGT2A1 HSD17B13 MYH16 AKR1B1 UTRN WDR72 ADAMTS3 DNAH2 USP43 MCM9 SLC28A1 MACF1 PLEKHM3 ATP1A3 | 1.25e-04 | 1275 | 225 | 23 | EFO_0004908 |
| Disease | Colonic Polyps | 1.73e-04 | 3 | 225 | 2 | C0009376 | |
| Disease | Cataract | 1.78e-04 | 37 | 225 | 4 | C0086543 | |
| Disease | Autistic Disorder | 1.91e-04 | 261 | 225 | 9 | C0004352 | |
| Disease | Malignant neoplasm of breast | MYH9 TBC1D9B TTC3 FAAH FASN CLCN1 SYNE2 DMD ANAPC5 NOS2 RASAL2 AKAP6 TMED1 DYNC2H1 RECQL JAKMIP3 NUP133 SLC28A1 MACF1 ATM | 2.32e-04 | 1074 | 225 | 20 | C0006142 |
| Disease | nephrotic syndrome type 20 (implicated_via_orthology) | 3.44e-04 | 4 | 225 | 2 | DOID:0070357 (implicated_via_orthology) | |
| Disease | Choledochal Cyst, Type I | 5.70e-04 | 5 | 225 | 2 | C0009439 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | Choledochal Cyst, Type II | 5.70e-04 | 5 | 225 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 5.70e-04 | 5 | 225 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 5.70e-04 | 5 | 225 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 5.70e-04 | 5 | 225 | 2 | C1257799 | |
| Disease | pain measurement | 5.70e-04 | 5 | 225 | 2 | EFO_0010639 | |
| Disease | Choledochal Cyst | 5.70e-04 | 5 | 225 | 2 | C0008340 | |
| Disease | melanoma | 6.69e-04 | 248 | 225 | 8 | C0025202 | |
| Disease | ankylosing spondylitis | 6.73e-04 | 91 | 225 | 5 | EFO_0003898 | |
| Disease | Profound Mental Retardation | 7.11e-04 | 139 | 225 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 7.11e-04 | 139 | 225 | 6 | C0025363 | |
| Disease | Mental deficiency | 7.11e-04 | 139 | 225 | 6 | C0917816 | |
| Disease | Congenital muscular dystrophy (disorder) | 8.51e-04 | 6 | 225 | 2 | C0699743 | |
| Disease | Endotoxic shock | 8.51e-04 | 6 | 225 | 2 | C0036981 | |
| Disease | Septic Shock | 8.51e-04 | 6 | 225 | 2 | C0036983 | |
| Disease | Toxic Shock Syndrome | 8.51e-04 | 6 | 225 | 2 | C0600327 | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 8.51e-04 | 6 | 225 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | brain edema (implicated_via_orthology) | 8.51e-04 | 6 | 225 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TRPM7 CFTR SACS ABCC8 PKHD1 DMD RASAL2 AKAP6 GRIN2A SLC44A4 ABCC6 PPP2R1B OSBP PYCARD | 1.06e-03 | 702 | 225 | 14 | C0009402 |
| Disease | response to tamsulosin | 1.19e-03 | 7 | 225 | 2 | GO_1901905 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.24e-03 | 28 | 225 | 3 | C0086432 | |
| Disease | Seizures | 1.48e-03 | 218 | 225 | 7 | C0036572 | |
| Disease | urate measurement | USP34 MYO9A GON4L BIRC6 FARP2 USP38 NRXN1 SCAPER PKHD1 CDC42BPG FOLR1 PPP2R1B SLC12A1 ANO6 SLC28A1 AKAP13 | 1.49e-03 | 895 | 225 | 16 | EFO_0004531 |
| Disease | Congestive heart failure | 1.58e-03 | 110 | 225 | 5 | C0018802 | |
| Disease | Heart failure | 1.58e-03 | 110 | 225 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.58e-03 | 110 | 225 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.58e-03 | 110 | 225 | 5 | C0235527 | |
| Disease | Heart Decompensation | 1.58e-03 | 110 | 225 | 5 | C1961112 | |
| Disease | Myocardial Failure | 1.58e-03 | 110 | 225 | 5 | C1959583 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.71e-03 | 112 | 225 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | waist circumference | 1.79e-03 | 429 | 225 | 10 | EFO_0004342 | |
| Disease | Xeroderma pigmentosum | 2.01e-03 | 9 | 225 | 2 | cv:C0043346 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.01e-03 | 9 | 225 | 2 | C0085548 | |
| Disease | coronary artery disease | TRPM7 MYO9B ZNF268 CFTR OTOL1 RRBP1 NEK9 HIRA RTF1 NRXN1 PKHD1 MCF2L WDR72 TTC41P ADAMTS3 DYNC2H1 USP43 PPP2R1B AKAP13 | 2.11e-03 | 1194 | 225 | 19 | EFO_0001645 |
| Disease | electroencephalogram measurement | 2.50e-03 | 74 | 225 | 4 | EFO_0004357 | |
| Disease | Focal glomerulosclerosis | 2.59e-03 | 36 | 225 | 3 | C0017668 | |
| Disease | uric acid measurement | USP34 TRPM7 MYO9A BIRC6 FARP2 AKR1B1 WDR72 CDC42BPG DYNC2H1 MYOF AKAP13 SNX1 | 2.67e-03 | 610 | 225 | 12 | EFO_0004761 |
| Disease | cataract (implicated_via_orthology) | 3.03e-03 | 38 | 225 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | Semantic-Pragmatic Disorder | 3.04e-03 | 11 | 225 | 2 | C0454655 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 3.04e-03 | 11 | 225 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Auditory Processing Disorder, Central | 3.04e-03 | 11 | 225 | 2 | C0751257 | |
| Disease | Basal cell carcinoma | 3.04e-03 | 11 | 225 | 2 | C0007117 | |
| Disease | Language Delay | 3.04e-03 | 11 | 225 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.04e-03 | 11 | 225 | 2 | C0023014 | |
| Disease | Speech Delay | 3.04e-03 | 11 | 225 | 2 | C0241210 | |
| Disease | alcohol consumption measurement | OTOL1 BIRC6 SPTBN5 NRXN1 PTPRK SCAPER PKHD1 MYH16 AKAP6 TOM1L2 DNAH2 RFX6 JAKMIP3 GK5 TTLL6 AKAP11 CTNNA1 ATP1A3 CDH4 | 3.25e-03 | 1242 | 225 | 19 | EFO_0007878 |
| Disease | Mental Depression | 3.48e-03 | 254 | 225 | 7 | C0011570 | |
| Disease | HVA measurement, MHPG measurement | 3.51e-03 | 40 | 225 | 3 | EFO_0005131, EFO_0005133 | |
| Disease | Cutaneous Melanoma | 3.77e-03 | 41 | 225 | 3 | C0151779 | |
| Disease | Tumoral calcinosis | 4.03e-03 | 42 | 225 | 3 | C0263628 | |
| Disease | Calcinosis | 4.03e-03 | 42 | 225 | 3 | C0006663 | |
| Disease | Microcalcification | 4.03e-03 | 42 | 225 | 3 | C0521174 | |
| Disease | Dystonia | 4.29e-03 | 86 | 225 | 4 | C0013421 | |
| Disease | Gastric Adenocarcinoma | 4.90e-03 | 45 | 225 | 3 | C0278701 | |
| Disease | revision of total hip arthroplasty | 4.96e-03 | 14 | 225 | 2 | EFO_0020973 | |
| Disease | Uterine leiomyoma | 5.24e-03 | 91 | 225 | 4 | HP_0000131 | |
| Disease | unipolar depression | TRIO SH3BP4 FASN SPINK4 NRXN1 NALCN SVIL SYNE2 PKD1 PKHD1 DMD NOS2 CCS RASA3 DYNC2H1 DNAH7 MCM9 CDH4 | 5.32e-03 | 1206 | 225 | 18 | EFO_0003761 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.65e-03 | 148 | 225 | 5 | C0279702 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 5.69e-03 | 15 | 225 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Dilated | 5.88e-03 | 48 | 225 | 3 | C0007193 | |
| Disease | Kidney Failure, Chronic | 5.88e-03 | 48 | 225 | 3 | C0022661 | |
| Disease | urinary uromodulin measurement | 6.33e-03 | 96 | 225 | 4 | EFO_0005663 | |
| Disease | Pre-Eclampsia | 6.47e-03 | 16 | 225 | 2 | C0032914 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 6.47e-03 | 16 | 225 | 2 | C0334634 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.47e-03 | 16 | 225 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 6.47e-03 | 16 | 225 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 6.59e-03 | 50 | 225 | 3 | C1449563 | |
| Disease | Depressive disorder | 6.96e-03 | 289 | 225 | 7 | C0011581 | |
| Disease | status epilepticus (biomarker_via_orthology) | 7.30e-03 | 100 | 225 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Benign neoplasm of stomach | 7.30e-03 | 17 | 225 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 7.30e-03 | 17 | 225 | 2 | C0496905 | |
| Disease | Dystonia, Limb | 7.30e-03 | 17 | 225 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 7.30e-03 | 17 | 225 | 2 | C0393610 | |
| Disease | Carcinoma in situ of stomach | 7.30e-03 | 17 | 225 | 2 | C0154060 | |
| Disease | sphingomyelin 14:0 measurement | 7.30e-03 | 17 | 225 | 2 | EFO_0010390 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 7.30e-03 | 17 | 225 | 2 | OBA_2045173 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.30e-03 | 17 | 225 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 7.35e-03 | 52 | 225 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Hereditary Diffuse Gastric Cancer | 7.48e-03 | 293 | 225 | 7 | C1708349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAEDAKWRVRLAIIE | 411 | P30153 | |
| VELAEDAKWRVRLAI | 421 | P30154 | |
| LEIQRVVEKADSWVE | 901 | Q8N163 | |
| ALIARVTNVEWLLDA | 121 | Q9ULZ3 | |
| WSNIEQVVEIKLRVE | 881 | Q96L91 | |
| RVLEEQLKSVREKWA | 66 | Q6UX73 | |
| WKVADEVGLRSVIEQ | 1316 | P13569 | |
| WEIVANVLEDTVKDL | 521 | Q9NR09 | |
| LWGAVLQESKVLERA | 666 | O15254 | |
| LALKTIDWVAFAEII | 6 | O75947 | |
| IESKQLEAESWSRII | 1966 | Q12802 | |
| ERIQIWAELAKVARK | 576 | Q8IYW2 | |
| LRIILQWLIASEAEV | 1826 | Q9UKA4 | |
| SDVWLDQVEVLEKLR | 291 | P56282 | |
| NTRWKLLQVAVEDRV | 3021 | P11532 | |
| ALVVWVTAFEAKRTI | 56 | P21730 | |
| SILVLWDINKRGVEE | 61 | Q7Z5P4 | |
| ILETIRIQWERDVEK | 271 | Q13515 | |
| VRKTVNDELRATIWE | 176 | Q14156 | |
| VEVHKWRQILRASVE | 676 | Q96CP6 | |
| SISKERWVETLVVAD | 241 | P58397 | |
| QVVKREELFIVSKLW | 66 | P15121 | |
| VVQWKITLSVLEAAV | 916 | Q8TBY9 | |
| DLSVVERAEVWLFLK | 146 | P08476 | |
| EVDGIKVRIQIWDTA | 51 | P59190 | |
| EERLWEVQRILTALK | 426 | Q15311 | |
| VDKLEIRVDLWNASN | 221 | Q14644 | |
| EEVETWLKAQVLERQ | 111 | O75943 | |
| VKRQWREEVASLQAV | 106 | Q15276 | |
| IEWLDTVVEQRVIKT | 466 | Q8HWS3 | |
| LQALERVCWIKDIVV | 81 | A4D126 | |
| LADILSWVNDEKVSR | 681 | Q6DT37 | |
| LVWLSIIAARKQSVE | 401 | Q15124 | |
| ELIDISIAQKTAIWR | 416 | Q9UJX4 | |
| LVSWLSAKEDVRSQV | 51 | Q7Z5J8 | |
| ALVNNILEIRVDAWK | 691 | Q4KMQ2 | |
| ILEIRVDAWKLTTQF | 696 | Q4KMQ2 | |
| LASLWKDQAVVEINI | 406 | P35228 | |
| DINRALKENITDAIW | 311 | Q8WUM0 | |
| EEAFKVLRAAWDIVS | 481 | Q6Y2X3 | |
| VLRAAWDIVSNAEKR | 486 | Q6Y2X3 | |
| VVDEWLLDKGRQLTI | 226 | P58400 | |
| EAAVAQVLEERQKAW | 346 | O60299 | |
| VEWKLRSDTAQVELT | 581 | Q96IV0 | |
| SLVVWKEVDLTRLSE | 76 | Q8TD19 | |
| KQARVLIVIAWSLSF | 161 | Q6W5P4 | |
| EVQAAWQKLVSAVAI | 126 | P02100 | |
| RRNKVAIVVSSLDWV | 241 | Q86UE6 | |
| IKHWITIIRARFEEV | 7001 | Q03001 | |
| TIIRARFEEVLAWAK | 7006 | Q03001 | |
| VKNAAANVLRETWLI | 391 | Q92952 | |
| VLLWSEVKDIQDVAV | 321 | Q9UPZ3 | |
| LRLQTWDEAVFREKI | 766 | O95786 | |
| REVGAKFWELLLVII | 876 | Q5H9U9 | |
| DIVKELIKWRAAIVV | 201 | Q9UK73 | |
| VIFINTRRKVDWLTE | 276 | P60842 | |
| TEWIEILKTVVNRDV | 226 | O95373 | |
| RKIWALEEENAKVVV | 1156 | O60437 | |
| IRIQETIDEWLKVQA | 896 | Q6ZR08 | |
| ARGAVEKWLIQVEDL | 1061 | Q6ZR08 | |
| RAENVLRLWIIEAKD | 166 | Q9UJF2 | |
| IIRARFEEVLTWAKQ | 2981 | O94854 | |
| VVIQARTVLTLAEKW | 676 | Q5VZ66 | |
| AEAEKTAERVIIWAR | 921 | P50748 | |
| TAERVIIWARLALQE | 926 | P50748 | |
| SWVLLVAILKDVQCE | 6 | A0A0J9YX35 | |
| LEGAWRTLIEKVQEA | 2431 | Q9UMN6 | |
| LWKDVDRIIGLDQVA | 611 | P35579 | |
| KRVIRTLWTVLDAID | 61 | Q8N0Y7 | |
| RSDITQVDWRVVLKT | 151 | Q6ZWE6 | |
| ASVDQTVKIWDLRQV | 261 | Q92466 | |
| VEIEQERVKSAGAWI | 71 | Q9P1Z3 | |
| WLQSREAKLRLAVVE | 231 | Q8NDA8 | |
| EGIKIVLEDIFTLWR | 116 | E9PIF3 | |
| VLEDIFTLWRQVETK | 121 | E9PIF3 | |
| VTELEQIRIEWELEK | 981 | Q9UPP2 | |
| VAEGVWKTSQERLVL | 251 | Q96M63 | |
| EVERQRWVTALELAK | 166 | P22059 | |
| KIASEIAQLSIAEWL | 541 | Q8WXE0 | |
| VSRATAELIWLNEKE | 686 | Q9UPN3 | |
| LADSLQLEKEVVRVW | 311 | P49335 | |
| KVLLDWINDVLVEER | 91 | Q9HBI1 | |
| WINDVLVEERIIVKQ | 96 | Q9HBI1 | |
| IAALLDLTERQVKVW | 176 | P14652 | |
| QRLEWVGLVESKIRI | 386 | P51003 | |
| EVVNSIVWVRQLELK | 481 | Q8NCM8 | |
| IVWVRQLELKVDDTI | 486 | Q8NCM8 | |
| SKEVAWNLTSVDLVR | 511 | Q15067 | |
| IIQGSLVEVDREFWK | 511 | Q13315 | |
| LWLIAAALVEVRTSA | 6 | O15072 | |
| WEKQVRVLTDAVDDI | 491 | P35221 | |
| FISKEILTIREAVWL | 366 | P41002 | |
| ILVKTLEWATIRIEK | 41 | Q53EU6 | |
| IEVWIILLEQLTAAV | 1451 | Q5TH69 | |
| ALVAVAWVRAEEELR | 11 | Q12841 | |
| VSEIKALWQAAEVER | 546 | Q8IYE1 | |
| EIEWREKAQDLALSL | 2166 | Q9BV73 | |
| ALRKESLEVEWTLVL | 46 | J3KSC0 | |
| ARGQVEKWLVELERV | 1136 | Q8WXX0 | |
| AWEATVLEKLNERTA | 201 | Q86WZ0 | |
| DIVVKVLKVRDWSTR | 216 | Q13418 | |
| EKVVLWTREADRVIL | 2151 | Q3T8J9 | |
| DSQTAEKWDAVVRLL | 106 | P55283 | |
| EKWDAVVRLLVAQTS | 111 | P55283 | |
| EQLKVWDVIGRSLII | 186 | O14618 | |
| VWETLLAALEVLIRA | 1931 | Q99698 | |
| TQLKEAAIGVLVLSW | 176 | Q5VSG8 | |
| VFSRLEVTRAEWEQK | 386 | P01854 | |
| EIRTFLASVQWKEVD | 996 | O00754 | |
| EIKAAWVNEIRKVLT | 931 | O15068 | |
| IQQIIKRAIEDADWI | 56 | A8MSI8 | |
| IVVVQWADLIICKTR | 916 | P13637 | |
| VLWIQFVAVIKEAVK | 66 | Q6ZS86 | |
| QETWLAALIVLAVLE | 306 | Q53GD3 | |
| NITLLWDREVADVLV | 596 | Q9H078 | |
| WLKITIANAVIGADV | 436 | O14640 | |
| LKKQVLSCEESIRVW | 436 | Q5T6L9 | |
| KTVIAQWRALDLDVV | 456 | O00519 | |
| EIREKTLANILAWLE | 121 | A6NE01 | |
| LSVWDVHRQVVVVKE | 796 | P54198 | |
| ALEKEVAIIVDQRAW | 366 | Q7Z3D6 | |
| WLKITIANAVIGADV | 411 | P54792 | |
| ASWLNLAEIAQVVEK | 796 | Q9BYK8 | |
| LKDLEVITVWFRSAV | 551 | O94887 | |
| DKAQVADVVVSRWLR | 1071 | P49327 | |
| ELAIEVALQNIAKTW | 1361 | Q9P225 | |
| VEDTKDGIWLVQVIA | 111 | O00237 | |
| FVSEIRRVVAALKWN | 86 | Q9H4I8 | |
| VRDFKALIDWIQLQE | 141 | Q9BY12 | |
| ILKEVTSVVEQAWKL | 4306 | Q9NZJ4 | |
| WQKLREESAARVVLT | 96 | Q16690 | |
| VLSKWLNDAQVVEAV | 691 | O94829 | |
| DWTIERVALNAKVVG | 226 | Q9Y597 | |
| EKEVRAAALVLQTIW | 816 | O60716 | |
| LLLVWVAVVGEAQTR | 11 | P15328 | |
| RVLREDWKQSVELAT | 181 | Q92845 | |
| EIKDVLVWSNDRVIR | 1101 | O75334 | |
| DICIKVWDLAQQVVL | 146 | Q9BQA1 | |
| VILKLSAGDQVWLEV | 431 | A6NHN0 | |
| VSWAQAQVRIVVLEA | 1956 | P98161 | |
| LKIAEIQARRIAVDW | 396 | Q15262 | |
| EVERARFIINDWVKT | 151 | P05121 | |
| IAALLDLTERQVKVW | 176 | O43364 | |
| DLKEIQRAVKLWVRS | 286 | Q9H488 | |
| ILVLLDTKNEDWDRI | 486 | Q9NXL9 | |
| EVGRWLVIALVQLAK | 106 | Q9Y5Y5 | |
| FVSEIRRVVAALKWN | 86 | Q9NQF3 | |
| IFWALEDSVLVVKAR | 541 | Q9P2B2 | |
| NAEEAALWRDLVRKV | 761 | Q9Y4G2 | |
| RNREWNIVESEKALV | 566 | Q92541 | |
| RLKEATVWIDAATQI | 301 | P23975 | |
| LNQRWDAIVAEVKDR | 2061 | P46939 | |
| LAENLGVTEDKVRVW | 136 | Q8NHV9 | |
| ESLKRVVVVEDIKRW | 31 | Q96MN5 | |
| EVLTREEWLKLFDNI | 581 | Q96DN5 | |
| LLTTAVEVAQRWREL | 846 | Q9P0V3 | |
| VEVAQRWRELAEKLA | 851 | Q9P0V3 | |
| ERKQLITVREEAWKT | 1186 | O95425 | |
| FEKEANIIVDRWLDI | 1616 | Q8WXH0 | |
| NIIVDRWLDINEKTE | 1621 | Q8WXH0 | |
| WKFVSEEIEREAIIL | 3471 | Q8WXH0 | |
| AIRKQEIEDRLNTWV | 5906 | Q8WXH0 | |
| FLESARWLIVKRQIE | 236 | Q8WUG5 | |
| RWLIVKRQIEEAQSV | 241 | Q8WUG5 | |
| LRWKCKVILESEVIA | 476 | O15226 | |
| IWAALETVQLKALVA | 1371 | O95255 | |
| KDWRDLFDVVIVQAE | 316 | Q86UY8 | |
| TGFRILVDQQVWKIE | 291 | Q9NYY8 | |
| KVVIDEVTRWLELAK | 151 | Q8NA58 | |
| QAWLVAAITATELLI | 381 | Q9BVG9 | |
| WVRTALIEKVLDKVV | 131 | O43147 | |
| ASVVDIKLLLRIWDL | 286 | Q96HU1 | |
| DVQEEIKEILRFWLT | 291 | Q07837 | |
| EWEAKAQVILLVILL | 321 | Q13621 | |
| AWTISRVVGQILVDK | 1316 | Q6ZUB1 | |
| TLAKKQWDSVVLERI | 111 | Q9BRX2 | |
| VVLILDSADAIWAIQ | 3411 | P08F94 | |
| LTIQKADEVVWVRAR | 51 | P14868 | |
| VATVAVLWVGKALRV | 81 | Q9NTN3 | |
| EDINARVSAIEKWVA | 1101 | Q13972 | |
| LQRVDLAEAWIQEKE | 2261 | Q9NRC6 | |
| SQEVAAWLREKNLVA | 2691 | Q9NRC6 | |
| KEVSLVVQWVDITRL | 191 | Q66K14 | |
| VVQWVDITRLEKNAT | 196 | Q66K14 | |
| WEALEIAQLKLVVKA | 1451 | Q09428 | |
| WILRALDTIKAEILA | 881 | Q13023 | |
| TLIDSWVDIAIFQLK | 231 | Q13155 | |
| REQAEEWLKVIREVS | 301 | Q8TED9 | |
| TAWKVLILLEAAVEE | 41 | Q17RA5 | |
| AVTQLLWERATEKVA | 751 | Q15021 | |
| FRVLAVWNKDAVTIT | 316 | P35523 | |
| VALLLVVVTWRVCQK | 141 | Q6UE05 | |
| KAQVWLRALETSVAA | 71 | P48736 | |
| VHRKWSANEIQVVVA | 356 | P46063 | |
| KEIVLADVIDNDSWR | 201 | P22234 | |
| WVAERVELLLKSESQ | 251 | P22234 | |
| FREEQEKLNVWVALL | 1651 | Q14690 | |
| LLLDWRQSAEEVIVK | 116 | O94966 | |
| EIHIVIWERKISQVT | 491 | Q5W0Q7 | |
| AEVTEQLAALVRALW | 141 | Q70EL4 | |
| EAVVREWILLEKGSI | 76 | Q9C0E2 | |
| ADRIAEIIKNDLWVN | 376 | Q9H2G4 | |
| RRIEKVLEWLFISQE | 56 | Q14587 | |
| IEILSEKAGIIQDTW | 671 | Q9P2E9 | |
| ELKLAVAWDRVDIAK | 351 | Q9NZQ8 | |
| LLAVAVRESWQTEEK | 16 | P20645 | |
| LQQAKDEILEWESRV | 446 | Q13596 | |
| FVLRLEGVIEKVNWD | 71 | Q9Y572 | |
| LWVEQLKVGVLVDEV | 576 | O94991 | |
| ESRIVEWTKKIQDIV | 396 | O94759 | |
| EAKLVIRWVDITQLE | 196 | Q6ZT07 | |
| LVTVKFEVWGLQTRV | 186 | Q9UKF7 | |
| LVVSVAGELKVWDLS | 176 | Q3MJ13 | |
| EAVSVQELWELVLKR | 561 | Q6P2S7 | |
| AVRLWDLRTAKEVQT | 191 | Q86W42 | |
| RAVAAEVSVLENWKE | 1636 | P53804 | |
| VVLRRIWEAEKDLFI | 61 | Q9UH36 | |
| DICVIRAIQKIIWAS | 1236 | O00507 | |
| DWRQLFDVVIVQADK | 286 | Q9H857 | |
| VEQIWRDIEDVIIKT | 301 | Q8N841 | |
| DAVKDIRWLVISLLE | 1681 | Q14997 | |
| EVIIVLERSESWNLK | 246 | P19474 | |
| VDTWVIALLKGLAAV | 286 | Q8NB14 | |
| TVRVLATKIWETNAV | 336 | P49190 | |
| KEFAILISLAIWVLV | 136 | Q9BXA5 | |
| DRKQWISVRAEVLTT | 521 | O00337 | |
| SRKLLEQEVVEITEW | 861 | Q9H6N6 | |
| WLNVKVILEELIVRG | 36 | Q6UWM9 | |
| WSAVNVAVLLLVAVL | 196 | Q13445 | |
| WETVALALGVQRLAK | 161 | Q53H54 | |
| IAKELADWLISNNVV | 361 | Q70CQ2 | |
| LLTAWENEQAVIERK | 821 | Q01831 | |
| TIVQDKVLALIQAWA | 111 | Q6ZVM7 | |
| AEITRLAVWAAVQAV | 181 | Q9ULD5 | |
| LAVWAAVQAVERKLE | 186 | Q9ULD5 | |
| WAIKLATNAAVTVLR | 506 | P50990 | |
| LALKIDLTEARVQVW | 131 | Q99453 | |
| ERIEGVIKDFVLTWL | 81 | P0DTE4 | |
| KEITWQTLRIEADAT | 181 | Q6BDS2 | |
| AVDLSEVVIKWELQR | 2006 | Q9Y4A5 | |
| AKILRAVVKIVEEWV | 2361 | Q9Y4A5 | |
| LILTLAWDRVDIAKN | 411 | Q96QT4 | |
| QDNDIKLRVSEWEVI | 306 | Q92995 | |
| DWIKHIREVIQERTI | 1581 | O75962 | |
| WSLREVVFVEDVKNV | 651 | O95071 | |
| ITLWTVVAAIQALEK | 41 | Q6ZMS7 | |
| WVIALALAALLVVDR | 6 | O60575 | |
| LAKARAWIADVDEIQ | 1026 | P41229 | |
| VLSLKGWVEVRDVII | 1111 | Q8IZF0 | |
| TAVALKEAWAAIIIQ | 801 | Q9NQX4 | |
| EIKDIELVLSQANVW | 176 | Q9BZK3 | |
| ELRAAAIVIQQKWRD | 1096 | B2RTY4 | |
| ITVSEKWRESVFRQI | 1491 | Q13459 | |
| RVIIWNTKDVILDEK | 1791 | Q9NZM1 | |
| LVVIVLNKDREWEKV | 361 | Q12879 |